| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter binding | ACTN2 RAPGEF3 VDAC1 SH3GL1 SH3GL2 YES1 PYCARD CNTNAP2 LYN FYN TP53 | 1.70e-06 | 172 | 205 | 11 | GO:0044325 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | EPS8 SYNPO2 MYO5A PSG5 STRBP INPPL1 TOGARAM1 CLSTN2 ACTN2 SPAG8 PTK2 GJA1 PTPN4 SYT11 FGD4 TLN2 NRAP NEBL DCTN2 SHROOM2 RCAN3 TTLL7 PYCARD ARHGEF2 LYN SCIN FYN MYBPC3 | 8.34e-06 | 1099 | 205 | 28 | GO:0008092 |
| GeneOntologyMolecularFunction | activin receptor activity, type I | 1.05e-05 | 5 | 205 | 3 | GO:0016361 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity, type I | 1.05e-05 | 5 | 205 | 3 | GO:0005025 | |
| GeneOntologyMolecularFunction | histone H3K27me2/H3K27me3 demethylase activity | 1.05e-05 | 5 | 205 | 3 | GO:0071558 | |
| GeneOntologyMolecularFunction | protein domain specific binding | TREX1 MYO5A INPPL1 TRPS1 TFDP3 ACTN2 DDB1 PTK2 GJA1 ZFYVE9 RAPGEF3 SH3GL1 GRIK2 SHROOM2 PIAS2 RBM39 TFDP1 SHANK2 PYCARD CNTNAP2 LYN FYN TP53 SON | 1.18e-05 | 875 | 205 | 24 | GO:0019904 |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 4.59e-05 | 20 | 205 | 4 | GO:0004675 | |
| GeneOntologyMolecularFunction | BMP receptor activity | 5.75e-05 | 8 | 205 | 3 | GO:0098821 | |
| GeneOntologyMolecularFunction | activin receptor activity | 8.56e-05 | 9 | 205 | 3 | GO:0017002 | |
| GeneOntologyMolecularFunction | GTPase binding | EPS8 MYO5A EXPH5 TBC1D7 SH3BP4 FGD4 STOML2 WDR44 SH3GL1 ARHGDIA ARHGDIB ARHGEF2 SORL1 | 9.40e-05 | 360 | 205 | 13 | GO:0051020 |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.82e-04 | 28 | 205 | 4 | GO:0141052 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.13e-04 | 156 | 205 | 8 | GO:0019838 | |
| GeneOntologyMolecularFunction | activin binding | 2.19e-04 | 12 | 205 | 3 | GO:0048185 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 2.73e-04 | 31 | 205 | 4 | GO:0032452 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 2.83e-04 | 13 | 205 | 3 | GO:0005024 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 3.10e-04 | 32 | 205 | 4 | GO:0140457 | |
| GeneOntologyMolecularFunction | Rho GDP-dissociation inhibitor activity | 3.13e-04 | 3 | 205 | 2 | GO:0005094 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 3.95e-04 | 93 | 205 | 6 | GO:0097110 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 4.28e-04 | 173 | 205 | 8 | GO:0070851 | |
| GeneOntologyMolecularFunction | actin binding | EPS8 SYNPO2 MYO5A PSG5 INPPL1 ACTN2 PTK2 FGD4 TLN2 NRAP NEBL SHROOM2 SCIN MYBPC3 | 4.51e-04 | 479 | 205 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | small GTPase binding | EPS8 MYO5A EXPH5 TBC1D7 SH3BP4 FGD4 WDR44 ARHGDIA ARHGDIB ARHGEF2 SORL1 | 5.05e-04 | 321 | 205 | 11 | GO:0031267 |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 5.44e-04 | 65 | 205 | 5 | GO:0016706 | |
| GeneOntologyMolecularFunction | lipid binding | PSG5 INPPL1 LAMA1 ACTN2 NOXO1 ZFYVE9 SYT11 OSBPL8 VDAC1 STOML2 UGT1A7 SH3GL1 SH3GL2 SHC1 CPNE5 ARHGDIA P2RX2 CADPS IGHM LYN SCIN HDLBP | 5.45e-04 | 988 | 205 | 22 | GO:0008289 |
| GeneOntologyMolecularFunction | phospholipid binding | PSG5 INPPL1 ACTN2 NOXO1 ZFYVE9 SYT11 OSBPL8 VDAC1 STOML2 SHC1 CPNE5 P2RX2 CADPS IGHM SCIN | 5.61e-04 | 548 | 205 | 15 | GO:0005543 |
| GeneOntologyMolecularFunction | triplex DNA binding | 6.21e-04 | 4 | 205 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | GDP-dissociation inhibitor activity | 6.52e-04 | 17 | 205 | 3 | GO:0005092 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 6.70e-04 | 39 | 205 | 4 | GO:0097718 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 1.01e-03 | 111 | 205 | 6 | GO:0003727 | |
| GeneOntologyMolecularFunction | kinase binding | ACACA MYO5A PSG5 ACVR1 ACVRL1 ADCY6 PTK2 GJA1 PIP5K1A VDAC1 DCTN2 UGT1A7 SH3GL2 SH2D3C SHC1 CCND2 ARHGDIA CADPS CSPG4 PAM TP53 | 1.03e-03 | 969 | 205 | 21 | GO:0019900 |
| GeneOntologyMolecularFunction | demethylase activity | 1.06e-03 | 44 | 205 | 4 | GO:0032451 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 1.26e-03 | 46 | 205 | 4 | GO:0004715 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | LYPLA2 ACTN2 ACVR1 PTK2 CEMIP2 NRXN3 TLN2 UBFD1 SH3GL1 ICAM4 ADAMTS13 CTNND2 LYN CDH17 HDLBP | 1.37e-03 | 599 | 205 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | protein kinase binding | MYO5A PSG5 ACVR1 ACVRL1 ADCY6 PTK2 GJA1 VDAC1 DCTN2 UGT1A7 SH3GL2 SH2D3C SHC1 CCND2 ARHGDIA CADPS CSPG4 PAM TP53 | 1.70e-03 | 873 | 205 | 19 | GO:0019901 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.83e-03 | 85 | 205 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.93e-03 | 86 | 205 | 5 | GO:0046332 | |
| GeneOntologyMolecularFunction | interleukin-6 receptor binding | 2.13e-03 | 7 | 205 | 2 | GO:0005138 | |
| GeneOntologyMolecularFunction | integrin binding | 2.25e-03 | 175 | 205 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.45e-03 | 227 | 205 | 8 | GO:0051015 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.38e-06 | 25 | 207 | 5 | GO:0038096 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 4.38e-06 | 25 | 207 | 5 | GO:0002433 | |
| GeneOntologyBiologicalProcess | muscle cell migration | MYO5A PTK2 BMP4 BMPR1A SEMA6D RAPGEF3 PLXNA1 MEGF10 IL6ST SORL1 | 5.43e-06 | 161 | 207 | 10 | GO:0014812 |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | TREX1 ACTN2 ACVR1 KDM6B GJA1 BMP4 BMPR1A SOX6 NPPB NRAP NEBL HCN4 CCND2 MYBPC3 | 5.97e-06 | 327 | 207 | 14 | GO:0048738 |
| GeneOntologyBiologicalProcess | heart development | TREX1 ACTN2 ACVR1 ACVR1B ACVRL1 KDM6B PTK2 GJA1 BMP4 BMPR1A KDM6A UTY SOX6 NPPB NPY2R NRAP NEBL HCN4 SHC1 CCND2 TP53 MYBPC3 | 8.17e-06 | 757 | 207 | 22 | GO:0007507 |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell migration | 8.58e-06 | 134 | 207 | 9 | GO:0014910 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPS8 LYPLA2 LAMA1 ETV1 PTK2 GJA1 DIP2A NRXN3 AGO4 SEMA6D FGD4 AFG3L2 PLXNA1 SOX6 PLXNA3 SH3GL2 FRYL CPNE5 SHROOM2 PIAS2 ARHGDIA IGHM CNTNAP2 ARHGEF2 CTNND2 LYN FYN CDH17 EPHA8 | 9.22e-06 | 1194 | 207 | 29 | GO:0000902 |
| GeneOntologyBiologicalProcess | striated muscle tissue development | TREX1 ACTN2 ACVR1 KDM6B GJA1 BMP4 BMPR1A SOX6 NPPB NRAP NEBL HCN4 CCND2 MYBPC3 | 1.25e-05 | 349 | 207 | 14 | GO:0014706 |
| GeneOntologyBiologicalProcess | smooth muscle cell migration | 1.62e-05 | 145 | 207 | 9 | GO:0014909 | |
| GeneOntologyBiologicalProcess | mesoderm formation | 1.86e-05 | 82 | 207 | 7 | GO:0001707 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | TREX1 MYO5A PSG5 INPPL1 ACTN2 ADCY6 PTK2 DDX11 GJA1 RAPGEF3 AFG3L2 PDXP OSBPL8 HCN4 SHC1 EPG5 ARHGEF2 LYN FYN TP53 SORL1 | 2.39e-05 | 752 | 207 | 21 | GO:1901699 |
| GeneOntologyBiologicalProcess | mesodermal cell differentiation | 2.46e-05 | 35 | 207 | 5 | GO:0048333 | |
| GeneOntologyBiologicalProcess | Fc receptor mediated stimulatory signaling pathway | 2.46e-05 | 35 | 207 | 5 | GO:0002431 | |
| GeneOntologyBiologicalProcess | mesoderm morphogenesis | 2.55e-05 | 86 | 207 | 7 | GO:0048332 | |
| GeneOntologyBiologicalProcess | regulation of chondrocyte differentiation | 2.75e-05 | 59 | 207 | 6 | GO:0032330 | |
| GeneOntologyBiologicalProcess | mesoderm development | 3.05e-05 | 157 | 207 | 9 | GO:0007498 | |
| GeneOntologyBiologicalProcess | endocytosis | IL10RA TREX1 PSG5 INPPL1 ATP9B LRP1B PTK2 SH3BP4 ZFYVE9 SYT11 PIP5K1A VAV3 SH3GL1 SH3GL2 YES1 IGHM PYCARD AP3B2 LYN FYN MEGF10 SORL1 | 3.17e-05 | 827 | 207 | 22 | GO:0006897 |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 3.66e-05 | 124 | 207 | 8 | GO:0001704 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway | 4.23e-05 | 39 | 207 | 5 | GO:0038094 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | EPS8 SYNPO2 PIEZO1 TOGARAM1 CLSTN2 ACTN2 ACVRL1 PTK2 DDX11 GJA1 BMP4 PHLDB1 RAPGEF3 PDXP PLXNA1 VDAC1 PLXNA3 SH3GL1 SH3GL2 PIAS2 IGHM PYCARD CNTNAP2 TMED9 PAN3 LYN SCIN FYN TP53 CDH17 | 4.30e-05 | 1366 | 207 | 30 | GO:0051130 |
| GeneOntologyBiologicalProcess | actin filament-based process | EPS8 SYNPO2 MYO5A INPPL1 ACTN2 GJA1 FGD4 RAPGEF3 PDXP PIP5K1A TLN2 UTY NRAP NEBL HCN4 SH3GL2 SHC1 SHROOM2 PYCARD PAM ARHGEF2 SCIN MYBPC3 | 4.75e-05 | 912 | 207 | 23 | GO:0030029 |
| GeneOntologyBiologicalProcess | cardiac conduction system development | 4.80e-05 | 40 | 207 | 5 | GO:0003161 | |
| GeneOntologyBiologicalProcess | muscle tissue development | TREX1 ACTN2 ACVR1 KDM6B GJA1 BMP4 BMPR1A SOX6 NPPB NRAP NEBL HCN4 CCND2 P2RX2 CNTNAP2 MEGF10 MYBPC3 | 5.12e-05 | 558 | 207 | 17 | GO:0060537 |
| GeneOntologyBiologicalProcess | gastrulation | 5.86e-05 | 212 | 207 | 10 | GO:0007369 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation | 6.03e-05 | 133 | 207 | 8 | GO:0002062 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | EPS8 SYNPO2 MYO5A INPPL1 ACTN2 GJA1 FGD4 RAPGEF3 PDXP PIP5K1A TLN2 NRAP NEBL SH3GL2 SHC1 SHROOM2 PYCARD PAM ARHGEF2 SCIN MYBPC3 | 6.18e-05 | 803 | 207 | 21 | GO:0030036 |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 7.76e-05 | 177 | 207 | 9 | GO:0055007 | |
| GeneOntologyBiologicalProcess | cardiocyte differentiation | 8.29e-05 | 221 | 207 | 10 | GO:0035051 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PSG5 PIEZO1 CLSTN2 ACVR1 PTK2 BMP4 FAT2 NRXN3 TLN2 COL8A2 PCDHGB6 PCDHGB3 PCDHGB2 ICAM4 SHC1 YES1 PYCARD DSG4 CTNND2 LYN FYN MEGF10 IL6ST CDH17 CD276 | 8.35e-05 | 1077 | 207 | 25 | GO:0098609 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | PIEZO1 LAMA1 ACTN2 ACVR1 KDM6B BMP4 BMPR1A AFG3L2 SOX6 NRAP NEBL CCND2 P2RX2 CNTNAP2 MEGF10 MYBPC3 | 9.71e-05 | 531 | 207 | 16 | GO:0042692 |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 1.00e-04 | 2 | 207 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | TREX1 ACVR1 ACVRL1 PTK2 GJA1 BMP4 BMPR1A KDM6A UTY NPY2R TP53 MYBPC3 | 1.03e-04 | 321 | 207 | 12 | GO:0003007 |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.05e-04 | 144 | 207 | 8 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of mesodermal cell differentiation | 1.13e-04 | 10 | 207 | 3 | GO:1905770 | |
| GeneOntologyBiologicalProcess | circulatory system development | TREX1 PSG5 LAMA1 ACTN2 ACVR1 ACVR1B ACVRL1 KDM6B PTK2 CEMIP2 GJA1 BMP4 BMPR1A NRXN3 RAPGEF3 VAV3 KDM6A UTY SOX6 NPPB COL8A2 NPY2R NRAP NEBL HCN4 SHC1 CCND2 CSPG4 TP53 MYBPC3 | 1.14e-04 | 1442 | 207 | 30 | GO:0072359 |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | PSG5 INPPL1 PTK2 HCST RAPGEF3 OSBPL8 PIP5K1A VAV3 WDR91 PPP2R1A CNTNAP2 FYN EPHA8 | 1.36e-04 | 382 | 207 | 13 | GO:0043491 |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | PSG5 PTK2 HCST RAPGEF3 OSBPL8 PIP5K1A VAV3 WDR91 PPP2R1A CNTNAP2 FYN EPHA8 | 1.49e-04 | 334 | 207 | 12 | GO:0051896 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-tyrosine phosphorylation | 1.50e-04 | 193 | 207 | 9 | GO:0050731 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | PSG5 INPPL1 TRPS1 ACVR1 ACVR1B ACVRL1 PTK2 BMP4 BMPR1A ZFYVE9 OSBPL8 NPPB SH2D3C SHC1 CHST11 LCP2 YES1 ADAMTS12 CSPG4 DSG4 LYN FYN IL6ST TP53 SORL1 EPHA8 | 1.50e-04 | 1186 | 207 | 26 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of cartilage development | 1.65e-04 | 81 | 207 | 6 | GO:0061035 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | PIEZO1 ACTN2 ACVR1 KDM6B BMP4 BMPR1A SOX6 NRAP NEBL CCND2 P2RX2 CNTNAP2 MYBPC3 | 1.71e-04 | 391 | 207 | 13 | GO:0051146 |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 2.06e-04 | 54 | 207 | 5 | GO:0048013 | |
| GeneOntologyBiologicalProcess | import into cell | IL10RA TREX1 PSG5 INPPL1 SLC38A5 ATP9B LRP1B PTK2 SH3BP4 ZFYVE9 SYT11 PIP5K1A VAV3 HCN4 SH3GL1 SH3GL2 YES1 IGHM PYCARD AP3B2 LYN FYN MEGF10 SORL1 | 2.07e-04 | 1074 | 207 | 24 | GO:0098657 |
| GeneOntologyBiologicalProcess | regulation of cell migration | SYNPO2 MYO5A PSG5 LAMA1 ACVR1 ACVR1B ACVRL1 PTK2 GJA1 BMP4 BMPR1A SEMA6D RAPGEF3 OSBPL8 PLXNA1 WDR44 GPI PLXNA3 ARHGDIA ARHGDIB PYCARD ARHGEF2 LYN IL6ST TP53 SORL1 | 2.09e-04 | 1211 | 207 | 26 | GO:0030334 |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | EPS8 PTK2 AGO4 FGD4 PLXNA1 PLXNA3 CPNE5 PIAS2 ARHGDIA IGHM FYN | 2.50e-04 | 302 | 207 | 11 | GO:0022604 |
| GeneOntologyBiologicalProcess | behavior | EPS8 MYO5A PSG5 STRBP ETV1 CLSTN2 GJA1 NRXN3 SYT11 RAPGEF3 VDAC1 GPI NPY2R GRIK2 CCND2 SHANK2 P2RX2 CNTNAP2 CTNND2 FYN TP53 | 2.60e-04 | 891 | 207 | 21 | GO:0007610 |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission, glutamatergic | 2.65e-04 | 13 | 207 | 3 | GO:0051967 | |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 2.99e-04 | 3 | 207 | 2 | GO:0071691 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 2.99e-04 | 3 | 207 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | muscle cell development | ACTN2 BMP4 BMPR1A AFG3L2 NRAP NEBL P2RX2 CNTNAP2 MEGF10 MYBPC3 | 3.01e-04 | 259 | 207 | 10 | GO:0055001 |
| GeneOntologyBiologicalProcess | learning | 3.02e-04 | 212 | 207 | 9 | GO:0007612 | |
| GeneOntologyBiologicalProcess | cell junction organization | IL10RA MYO5A PSG5 CLSTN2 ACTN2 ACVRL1 PTK2 GJA1 DIP2A NRXN3 AFG3L2 PDXP PIP5K1A TLN2 SH3GL2 SHROOM2 SHANK2 P2RX2 CNTNAP2 CTNND2 FYN CDH17 | 3.32e-04 | 974 | 207 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 3.66e-04 | 61 | 207 | 5 | GO:0030834 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | SYNPO2 IL16 MYO5A PSG5 LAMA1 ACVR1 ACVR1B ACVRL1 PTK2 GJA1 BMP4 BMPR1A SEMA6D RAPGEF3 OSBPL8 PLXNA1 WDR44 GPI PLXNA3 ARHGDIA ARHGDIB PYCARD ARHGEF2 LYN IL6ST TP53 SORL1 | 3.68e-04 | 1327 | 207 | 27 | GO:0040012 |
| GeneOntologyBiologicalProcess | negative regulation of neurogenesis | 3.69e-04 | 173 | 207 | 8 | GO:0050768 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 3.95e-04 | 62 | 207 | 5 | GO:0038093 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | TREX1 MYO5A PSG5 INPPL1 ACTN2 ADCY6 PTK2 DDX11 GJA1 RAPGEF3 UCP3 AFG3L2 PDXP OSBPL8 HCN4 SHC1 ADAMTS13 CREM EPG5 P2RX2 CNTNAP2 ARHGEF2 LYN FYN TP53 SORL1 | 4.44e-04 | 1272 | 207 | 26 | GO:1901698 |
| GeneOntologyBiologicalProcess | phagocytosis | 4.69e-04 | 274 | 207 | 10 | GO:0006909 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | SYNPO2 MYO5A PSG5 LAMA1 ACVR1 ACVR1B ACVRL1 PTK2 GJA1 BMP4 BMPR1A SEMA6D RAPGEF3 OSBPL8 PLXNA1 WDR44 GPI PLXNA3 ARHGDIA ARHGDIB PYCARD ARHGEF2 LYN IL6ST TP53 SORL1 | 4.88e-04 | 1280 | 207 | 26 | GO:2000145 |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 4.89e-04 | 327 | 207 | 11 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 5.15e-04 | 329 | 207 | 11 | GO:0018212 | |
| GeneOntologyBiologicalProcess | endothelium development | 5.18e-04 | 182 | 207 | 8 | GO:0003158 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 5.27e-04 | 66 | 207 | 5 | GO:0030042 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | EPS8 ACTN2 ADCY6 PTK2 GJA1 SEMA6D RAPGEF3 PDXP VAV3 KDM6A PLXNA3 NPPB SHC1 SHROOM2 PYCARD SCIN | 5.29e-04 | 618 | 207 | 16 | GO:0090066 |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 5.56e-04 | 184 | 207 | 8 | GO:0051961 | |
| GeneOntologyBiologicalProcess | leukocyte proliferation | PSG5 PTK2 GJA1 BMP4 VAV3 IKZF3 IGHM PYCARD LYN FYN IL6ST TP53 CD276 | 5.87e-04 | 445 | 207 | 13 | GO:0070661 |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 5.99e-04 | 233 | 207 | 9 | GO:0031345 | |
| GeneOntologyBiologicalProcess | mechanosensory behavior | 6.11e-04 | 17 | 207 | 3 | GO:0007638 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 6.19e-04 | 187 | 207 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | EPS8 PSG5 ACVRL1 PTK2 CEMIP2 GJA1 BMP4 BMPR1A PHLDB1 AGO4 SEMA6D FGD4 RAPGEF3 PLXNA1 PLXNA3 NPPB SHC1 CPNE5 PIAS2 ADAMTS12 ARHGDIA IGHM FYN | 6.27e-04 | 1090 | 207 | 23 | GO:0022603 |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | TREX1 ACACA MYO5A PSG5 INPPL1 IRAK2 ACTN2 KDM6B ADCY6 PTK2 DDX11 GJA1 BMP4 RAPGEF3 AFG3L2 PDXP OSBPL8 KDM6A HCN4 SHC1 ADAMTS13 YES1 PYCARD ARHGEF2 LYN FYN TP53 SORL1 | 6.51e-04 | 1450 | 207 | 28 | GO:1901701 |
| GeneOntologyBiologicalProcess | neuron projection guidance | 6.53e-04 | 286 | 207 | 10 | GO:0097485 | |
| GeneOntologyBiologicalProcess | actin filament organization | EPS8 SYNPO2 MYO5A INPPL1 ACTN2 GJA1 RAPGEF3 PDXP NRAP NEBL SHROOM2 PYCARD ARHGEF2 SCIN | 6.58e-04 | 509 | 207 | 14 | GO:0007015 |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 6.70e-04 | 105 | 207 | 6 | GO:1901879 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | PSG5 GJA1 BMP4 VAV3 IKZF3 IGHM PYCARD LYN FYN IL6ST TP53 CD276 | 7.23e-04 | 398 | 207 | 12 | GO:0046651 |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | ACVR1 ACVRL1 PTK2 BMPR1A ZFYVE9 SOX6 MXRA5 CHST11 YES1 FYN TP53 | 7.26e-04 | 343 | 207 | 11 | GO:0071559 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | EPS8 SYNPO2 TOGARAM1 ACTN2 PTK2 GJA1 PHLDB1 RAPGEF3 PDXP PLXNA3 SHROOM2 PYCARD PAM ARHGEF2 SCIN | 7.84e-04 | 579 | 207 | 15 | GO:0051493 |
| GeneOntologyBiologicalProcess | regulation of trophoblast cell migration | 8.57e-04 | 19 | 207 | 3 | GO:1901163 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | PSG5 GJA1 BMP4 VAV3 IKZF3 IGHM PYCARD LYN FYN IL6ST TP53 CD276 | 8.59e-04 | 406 | 207 | 12 | GO:0032943 |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 8.95e-04 | 43 | 207 | 4 | GO:0060391 | |
| GeneOntologyBiologicalProcess | endocardial cushion morphogenesis | 9.77e-04 | 44 | 207 | 4 | GO:0003203 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | EPS8 TREX1 SYNPO2 MYO5A TBC1D7 TOGARAM1 ACTN2 PTK2 DDX11 GJA1 BMP4 PHLDB1 SYT11 RAPGEF3 PDXP VDAC1 WDR44 PLXNA3 SHROOM2 PYCARD PAM TMED9 PAN3 ARHGEF2 SCIN TP53 | 9.78e-04 | 1342 | 207 | 26 | GO:0033043 |
| GeneOntologyBiologicalProcess | microspike assembly | 9.83e-04 | 5 | 207 | 2 | GO:0030035 | |
| GeneOntologyBiologicalProcess | trophoblast cell migration | 1.00e-03 | 20 | 207 | 3 | GO:0061450 | |
| GeneOntologyCellularComponent | glutamatergic synapse | EPS8 MYO5A RTN3 CLSTN2 ACTN2 PTK2 DIP2A NRXN3 PDXP PLXNA1 SH3GL1 SH3GL2 GRIK2 YES1 PPP2R1A SHANK2 P2RX2 CADPS CNTNAP2 ARHGEF2 CTNND2 LYN FYN | 5.78e-06 | 817 | 205 | 23 | GO:0098978 |
| GeneOntologyCellularComponent | neuronal cell body | PDE9A MYO5A ACVRL1 BMPR1A SYT11 RAPGEF3 HCN4 SH3GL2 GRIK2 CPNE5 SHROOM2 TTLL7 PPP2R1A SHANK2 P2RX2 PYCARD CNTNAP2 PAM ARHGEF2 CTNND2 FYN IL6ST SORL1 | 8.23e-06 | 835 | 205 | 23 | GO:0043025 |
| GeneOntologyCellularComponent | anchoring junction | SYNPO2 IL16 PSG5 LAMA1 ACTN2 PTK2 GJA1 FAT2 PDXP PIP5K1A TLN2 NRAP SH3GL1 SHC1 LCP2 SHROOM2 YES1 CSPG4 CNTNAP2 DSG4 ARHGEF2 CTNND2 LYN SCIN CDH17 | 1.13e-05 | 976 | 205 | 25 | GO:0070161 |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 1.78e-05 | 56 | 205 | 6 | GO:0099091 | |
| GeneOntologyCellularComponent | somatodendritic compartment | PDE9A MYO5A CLSTN2 ACTN2 ACVRL1 PTK2 DIP2A BMPR1A SYT11 RAPGEF3 HCN4 SH3GL2 GRIK2 CPNE5 SHROOM2 TTLL7 PPP2R1A SHANK2 P2RX2 PYCARD CNTNAP2 PAM ARHGEF2 CTNND2 FYN IL6ST SORL1 EPHA8 | 2.74e-05 | 1228 | 205 | 28 | GO:0036477 |
| GeneOntologyCellularComponent | cell leading edge | EPS8 PDE9A MYO5A INPPL1 PIEZO1 PTK2 FGD4 RAPGEF3 PDXP PIP5K1A TLN2 SH2D3C DUOXA1 CSPG4 CNTNAP2 ARHGEF2 | 3.64e-05 | 500 | 205 | 16 | GO:0031252 |
| GeneOntologyCellularComponent | ruffle | EPS8 PDE9A MYO5A FGD4 PDXP PIP5K1A TLN2 SH2D3C CSPG4 ARHGEF2 | 3.79e-05 | 206 | 205 | 10 | GO:0001726 |
| GeneOntologyCellularComponent | cell body | PDE9A MYO5A ACVRL1 BMPR1A SYT11 RAPGEF3 HCN4 SH3GL2 GRIK2 CPNE5 SHROOM2 TTLL7 PPP2R1A SHANK2 P2RX2 PYCARD CNTNAP2 PAM ARHGEF2 CTNND2 FYN IL6ST SORL1 | 4.41e-05 | 929 | 205 | 23 | GO:0044297 |
| GeneOntologyCellularComponent | actin cytoskeleton | SYNPO2 ACACA MYO5A ACTN2 PTK2 RAPGEF3 PDXP TLN2 STOML2 NEBL DCTN2 SH3GL1 SHROOM2 YES1 ARHGEF2 SCIN FYN | 5.69e-05 | 576 | 205 | 17 | GO:0015629 |
| GeneOntologyCellularComponent | cell projection membrane | EPS8 PDE9A PSG5 PIEZO1 ADCY6 RAPGEF3 PDXP PIP5K1A GPI SH2D3C SHANK2 CSPG4 CNTNAP2 ARHGEF2 | 9.63e-05 | 431 | 205 | 14 | GO:0031253 |
| GeneOntologyCellularComponent | dendrite | MYO5A CLSTN2 ACTN2 ACVRL1 PTK2 DIP2A BMPR1A SYT11 HCN4 SH3GL2 GRIK2 TTLL7 PPP2R1A SHANK2 P2RX2 CNTNAP2 ARHGEF2 CTNND2 FYN IL6ST EPHA8 | 1.13e-04 | 858 | 205 | 21 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | MYO5A CLSTN2 ACTN2 ACVRL1 PTK2 DIP2A BMPR1A SYT11 HCN4 SH3GL2 GRIK2 TTLL7 PPP2R1A SHANK2 P2RX2 CNTNAP2 ARHGEF2 CTNND2 FYN IL6ST EPHA8 | 1.17e-04 | 860 | 205 | 21 | GO:0097447 |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.92e-04 | 12 | 205 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | leading edge membrane | 2.37e-04 | 210 | 205 | 9 | GO:0031256 | |
| GeneOntologyCellularComponent | fascia adherens | 2.47e-04 | 13 | 205 | 3 | GO:0005916 | |
| GeneOntologyCellularComponent | cell-cell junction | PSG5 LAMA1 PTK2 GJA1 FAT2 PDXP TLN2 NRAP LCP2 SHROOM2 CNTNAP2 DSG4 ARHGEF2 CTNND2 LYN CDH17 | 2.52e-04 | 591 | 205 | 16 | GO:0005911 |
| GeneOntologyCellularComponent | terminal bouton | 3.68e-04 | 96 | 205 | 6 | GO:0043195 | |
| GeneOntologyCellularComponent | perikaryon | 3.69e-04 | 223 | 205 | 9 | GO:0043204 | |
| GeneOntologyCellularComponent | postsynaptic specialization | EPS8 RTN3 CLSTN2 ACTN2 SYT11 VDAC1 SH3GL1 GRIK2 YES1 SHANK2 ARHGEF2 CTNND2 LYN FYN | 4.67e-04 | 503 | 205 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | BMP receptor complex | 5.67e-04 | 4 | 205 | 2 | GO:0070724 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | EPS8 RTN3 CLSTN2 ACTN2 SYT11 VDAC1 SH3GL1 SH3GL2 GRIK2 SHANK2 CNTNAP2 ARHGEF2 CTNND2 FYN | 6.84e-04 | 523 | 205 | 14 | GO:0098984 |
| GeneOntologyCellularComponent | ruffle membrane | 6.90e-04 | 108 | 205 | 6 | GO:0032587 | |
| GeneOntologyCellularComponent | asymmetric synapse | EPS8 RTN3 CLSTN2 ACTN2 SYT11 VDAC1 SH3GL1 GRIK2 SHANK2 CNTNAP2 ARHGEF2 CTNND2 FYN | 9.00e-04 | 477 | 205 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.02e-03 | 78 | 205 | 5 | GO:0048787 | |
| GeneOntologyCellularComponent | postsynapse | EPS8 MYO5A RTN3 CLSTN2 ACTN2 PTK2 DIP2A SYT11 PDXP VDAC1 SH3GL1 SH3GL2 GRIK2 YES1 SHANK2 P2RX2 CNTNAP2 ARHGEF2 CTNND2 LYN FYN | 1.08e-03 | 1018 | 205 | 21 | GO:0098794 |
| GeneOntologyCellularComponent | lamellipodium membrane | 1.25e-03 | 22 | 205 | 3 | GO:0031258 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 1.35e-03 | 49 | 205 | 4 | GO:0099092 | |
| GeneOntologyCellularComponent | Rb-E2F complex | 1.40e-03 | 6 | 205 | 2 | GO:0035189 | |
| GeneOntologyCellularComponent | activin receptor complex | 1.40e-03 | 6 | 205 | 2 | GO:0048179 | |
| GeneOntologyCellularComponent | super elongation complex | 1.40e-03 | 6 | 205 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | cell-substrate junction | SYNPO2 IL16 ACTN2 PTK2 GJA1 PIP5K1A TLN2 NRAP SHC1 YES1 CSPG4 ARHGEF2 | 1.48e-03 | 443 | 205 | 12 | GO:0030055 |
| GeneOntologyCellularComponent | postsynaptic density | EPS8 RTN3 CLSTN2 ACTN2 SYT11 VDAC1 SH3GL1 GRIK2 SHANK2 ARHGEF2 CTNND2 FYN | 1.72e-03 | 451 | 205 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | receptor complex | EPS8 PSG5 ACVR1 ACVR1B ACVRL1 LRP1B BMPR1A PLXNA1 PLXNA3 GRIK2 P2RX2 IGHM LYN IL6ST | 1.85e-03 | 581 | 205 | 14 | GO:0043235 |
| GeneOntologyCellularComponent | lamellipodium | 2.01e-03 | 230 | 205 | 8 | GO:0030027 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 2.48e-03 | 350 | 205 | 10 | GO:0098802 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.71e-03 | 141 | 205 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | focal adhesion | SYNPO2 IL16 ACTN2 PTK2 GJA1 PIP5K1A TLN2 SHC1 YES1 CSPG4 ARHGEF2 | 3.65e-03 | 431 | 205 | 11 | GO:0005925 |
| MousePheno | abnormal spleen marginal zone morphology | 1.10e-05 | 115 | 170 | 9 | MP:0002362 | |
| Domain | GS_dom | 4.81e-07 | 7 | 205 | 4 | IPR003605 | |
| Domain | GS | 4.81e-07 | 7 | 205 | 4 | PS51256 | |
| Domain | TGF_beta_GS | 4.81e-07 | 7 | 205 | 4 | PF08515 | |
| Domain | GS | 4.81e-07 | 7 | 205 | 4 | SM00467 | |
| Domain | Laminin_G | 3.24e-06 | 58 | 205 | 7 | IPR001791 | |
| Domain | LAM_G_DOMAIN | 3.35e-06 | 38 | 205 | 6 | PS50025 | |
| Domain | Laminin_G_2 | 4.57e-06 | 40 | 205 | 6 | PF02210 | |
| Domain | TGFB_receptor | 6.51e-06 | 12 | 205 | 4 | IPR000333 | |
| Domain | LamG | 8.10e-06 | 44 | 205 | 6 | SM00282 | |
| Domain | - | 9.86e-06 | 95 | 205 | 8 | 2.60.120.200 | |
| Domain | SH3_1 | 1.38e-05 | 164 | 205 | 10 | PF00018 | |
| Domain | SH2 | 1.55e-05 | 101 | 205 | 8 | PF00017 | |
| Domain | SH3 | EPS8 SH3BP4 NOXO1 VAV3 NEBL SH3GL1 SH3GL2 YES1 SHANK2 LYN FYN | 2.77e-05 | 216 | 205 | 11 | SM00326 |
| Domain | SH3 | EPS8 SH3BP4 NOXO1 VAV3 NEBL SH3GL1 SH3GL2 YES1 SHANK2 LYN FYN | 2.77e-05 | 216 | 205 | 11 | PS50002 |
| Domain | SH2 | 2.89e-05 | 110 | 205 | 8 | SM00252 | |
| Domain | SH2 | 3.08e-05 | 111 | 205 | 8 | PS50001 | |
| Domain | SH3_domain | EPS8 SH3BP4 NOXO1 VAV3 NEBL SH3GL1 SH3GL2 YES1 SHANK2 LYN FYN | 3.28e-05 | 220 | 205 | 11 | IPR001452 |
| Domain | SH2 | 3.29e-05 | 112 | 205 | 8 | IPR000980 | |
| Domain | - | 3.29e-05 | 112 | 205 | 8 | 3.30.505.10 | |
| Domain | JmjC | 1.26e-04 | 24 | 205 | 4 | PF02373 | |
| Domain | Activin_recp | 1.48e-04 | 10 | 205 | 3 | PF01064 | |
| Domain | Activin_recp | 1.48e-04 | 10 | 205 | 3 | IPR000472 | |
| Domain | CADHERIN_1 | 2.50e-04 | 113 | 205 | 7 | PS00232 | |
| Domain | Cadherin | 2.50e-04 | 113 | 205 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 2.64e-04 | 114 | 205 | 7 | PS50268 | |
| Domain | - | 2.64e-04 | 114 | 205 | 7 | 2.60.40.60 | |
| Domain | CA | 2.79e-04 | 115 | 205 | 7 | SM00112 | |
| Domain | Cadherin-like | 2.94e-04 | 116 | 205 | 7 | IPR015919 | |
| Domain | Cadherin | 3.27e-04 | 118 | 205 | 7 | IPR002126 | |
| Domain | RhoGDI_domain | 3.57e-04 | 3 | 205 | 2 | IPR024792 | |
| Domain | DP | 3.57e-04 | 3 | 205 | 2 | PF08781 | |
| Domain | Rho_GDI | 3.57e-04 | 3 | 205 | 2 | PF02115 | |
| Domain | - | 3.57e-04 | 3 | 205 | 2 | 2.70.50.30 | |
| Domain | Transcrpt_fac_DP | 3.57e-04 | 3 | 205 | 2 | IPR015648 | |
| Domain | Transc_factor_DP_C | 3.57e-04 | 3 | 205 | 2 | IPR014889 | |
| Domain | Rho_GDI | 3.57e-04 | 3 | 205 | 2 | IPR000406 | |
| Domain | DP | 3.57e-04 | 3 | 205 | 2 | SM01138 | |
| Domain | JMJC | 3.98e-04 | 32 | 205 | 4 | PS51184 | |
| Domain | JmjC_dom | 3.98e-04 | 32 | 205 | 4 | IPR003347 | |
| Domain | SAM | 4.17e-04 | 88 | 205 | 6 | SM00454 | |
| Domain | JmjC | 4.49e-04 | 33 | 205 | 4 | SM00558 | |
| Domain | Pkinase_Tyr | 5.60e-04 | 129 | 205 | 7 | PF07714 | |
| Domain | SAM_DOMAIN | 6.28e-04 | 95 | 205 | 6 | PS50105 | |
| Domain | SAM | 7.01e-04 | 97 | 205 | 6 | IPR001660 | |
| Domain | Nebulin | 7.09e-04 | 4 | 205 | 2 | PF00880 | |
| Domain | NEBULIN | 7.09e-04 | 4 | 205 | 2 | PS51216 | |
| Domain | NEBU | 7.09e-04 | 4 | 205 | 2 | SM00227 | |
| Domain | Nebulin | 7.09e-04 | 4 | 205 | 2 | IPR013998 | |
| Domain | TF_AF4/FMR2 | 7.09e-04 | 4 | 205 | 2 | IPR007797 | |
| Domain | Nebulin_repeat | 7.09e-04 | 4 | 205 | 2 | IPR000900 | |
| Domain | AF-4 | 7.09e-04 | 4 | 205 | 2 | PF05110 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 8.35e-04 | 138 | 205 | 7 | IPR001245 | |
| Domain | PH_dom-like | EPS8 PTK2 PTPN4 PHLDB1 FGD4 OSBPL8 TLN2 VAV3 MTMR8 SHC1 CADPS FRMPD3 ARHGEF2 | 8.88e-04 | 426 | 205 | 13 | IPR011993 |
| Domain | SAM_1 | 9.03e-04 | 68 | 205 | 5 | PF00536 | |
| Domain | PDZ | 9.48e-04 | 141 | 205 | 7 | PF00595 | |
| Domain | - | 1.12e-03 | 106 | 205 | 6 | 1.10.150.50 | |
| Domain | PDZ | 1.26e-03 | 148 | 205 | 7 | SM00228 | |
| Domain | Cadherin_CS | 1.29e-03 | 109 | 205 | 6 | IPR020894 | |
| Domain | - | 1.36e-03 | 150 | 205 | 7 | 2.30.42.10 | |
| Domain | PDZ | 1.41e-03 | 151 | 205 | 7 | PS50106 | |
| Domain | PDZ | 1.47e-03 | 152 | 205 | 7 | IPR001478 | |
| Domain | FERM_M | 1.60e-03 | 46 | 205 | 4 | PF00373 | |
| Domain | SAM/pointed | 1.85e-03 | 117 | 205 | 6 | IPR013761 | |
| Domain | FERM_central | 2.03e-03 | 49 | 205 | 4 | IPR019748 | |
| Domain | FERM_domain | 2.03e-03 | 49 | 205 | 4 | IPR000299 | |
| Domain | FERM_1 | 2.19e-03 | 50 | 205 | 4 | PS00660 | |
| Domain | FERM_2 | 2.19e-03 | 50 | 205 | 4 | PS00661 | |
| Domain | FERM_3 | 2.19e-03 | 50 | 205 | 4 | PS50057 | |
| Domain | Band_41_domain | 2.19e-03 | 50 | 205 | 4 | IPR019749 | |
| Domain | B41 | 2.19e-03 | 50 | 205 | 4 | SM00295 | |
| Domain | EGF_2 | 2.69e-03 | 265 | 205 | 9 | PS01186 | |
| Domain | Tyr_kinase_cat_dom | 2.84e-03 | 88 | 205 | 5 | IPR020635 | |
| Domain | TyrKc | 2.84e-03 | 88 | 205 | 5 | SM00219 | |
| Pathway | REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS | 2.16e-05 | 31 | 157 | 5 | M46423 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 3.45e-05 | 34 | 157 | 5 | MM15025 | |
| Pathway | PID_EPHA_FWDPATHWAY | 3.45e-05 | 34 | 157 | 5 | M177 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | LYPLA2 PTK2 SEMA6D VAV3 PLXNA1 PLXNA3 SH3GL2 SHC1 YES1 LYN FYN EPHA8 | 3.56e-05 | 261 | 157 | 12 | MM15676 |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 4.01e-05 | 18 | 157 | 4 | MM15023 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 4.78e-05 | 86 | 157 | 7 | M2642 | |
| Pathway | PID_EPHA2_FWD_PATHWAY | 5.04e-05 | 19 | 157 | 4 | M273 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 7.64e-05 | 21 | 157 | 4 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 7.64e-05 | 21 | 157 | 4 | MM14996 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 8.33e-05 | 65 | 157 | 6 | MM14911 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 8.72e-05 | 41 | 157 | 5 | MM15162 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.08e-04 | 9 | 157 | 3 | MM15030 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 1.23e-04 | 44 | 157 | 5 | MM15377 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 1.25e-04 | 100 | 157 | 7 | MM15826 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | KDM3A ACVR1 ACVR1B KDM6B DDB1 BMP4 KDM6A NPPB PIAS2 PPP2R1A IL6ST TP53 | 1.39e-04 | 301 | 157 | 12 | MM15983 |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 1.87e-04 | 48 | 157 | 5 | M914 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 2.13e-04 | 27 | 157 | 4 | M33 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 2.50e-04 | 51 | 157 | 5 | M27311 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 2.77e-04 | 12 | 157 | 3 | MM14835 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 2.77e-04 | 12 | 157 | 3 | MM15452 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 2.77e-04 | 12 | 157 | 3 | M11773 | |
| Pathway | REACTOME_DAP12_SIGNALING | 2.83e-04 | 29 | 157 | 4 | M27171 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 2.83e-04 | 29 | 157 | 4 | M27309 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 2.83e-04 | 29 | 157 | 4 | MM14934 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 3.27e-04 | 54 | 157 | 5 | MM14871 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 3.57e-04 | 13 | 157 | 3 | MM14565 | |
| Pathway | REACTOME_DAP12_SIGNALING | 3.69e-04 | 31 | 157 | 4 | MM14886 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 4.51e-04 | 14 | 157 | 3 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 4.51e-04 | 14 | 157 | 3 | M7578 | |
| Pathway | PID_FCER1_PATHWAY | 5.36e-04 | 60 | 157 | 5 | M7 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 5.59e-04 | 15 | 157 | 3 | MM15031 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 5.62e-04 | 92 | 157 | 6 | M27201 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 5.92e-04 | 35 | 157 | 4 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 5.92e-04 | 35 | 157 | 4 | M773 | |
| Pathway | PID_PDGFRB_PATHWAY | 5.97e-04 | 129 | 157 | 7 | M186 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 6.82e-04 | 16 | 157 | 3 | M16498 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 6.82e-04 | 16 | 157 | 3 | M8245 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 6.82e-04 | 16 | 157 | 3 | M537 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 6.82e-04 | 16 | 157 | 3 | M9450 | |
| Pathway | BIOCARTA_ALK_PATHWAY | 7.35e-04 | 37 | 157 | 4 | M17400 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 7.35e-04 | 37 | 157 | 4 | MM15022 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 7.77e-04 | 219 | 157 | 9 | M29836 | |
| Pathway | PID_RAC1_REG_PATHWAY | 8.14e-04 | 38 | 157 | 4 | M241 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 8.31e-04 | 66 | 157 | 5 | MM15925 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.15e-03 | 19 | 157 | 3 | M47733 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 1.16e-03 | 71 | 157 | 5 | MM15604 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.19e-03 | 42 | 157 | 4 | M27308 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPH_TO_TCR_NFAT_SIGNALING_PATHWAY | 1.21e-03 | 5 | 157 | 2 | M48994 | |
| Pathway | REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA | 1.21e-03 | 5 | 157 | 2 | M26903 | |
| Pathway | REACTOME_SIGNALING_BY_INTERLEUKINS | 1.21e-03 | 281 | 157 | 10 | MM15130 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.22e-03 | 188 | 157 | 8 | MM15828 | |
| Pubmed | KDM6B interacts with TFDP1 to activate P53 signaling in regulating mouse palatogenesis. | 3.53e-10 | 16 | 211 | 6 | 35212626 | |
| Pubmed | EPS8 IL16 MYO5A RTN3 ACTN2 DDB1 GJA1 DIP2A PHLDB1 FGD4 AFG3L2 OSBPL8 TLN2 VDAC1 STOML2 GPI DCTN2 SH3GL1 SHROOM2 RBM39 ARHGDIA PPP2R1A SHANK2 CADPS KIAA1217 IGHM AP3B2 TMED9 ARHGEF2 CTNND2 HDLBP | 8.54e-10 | 1431 | 211 | 31 | 37142655 | |
| Pubmed | BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy. | 1.32e-09 | 4 | 211 | 4 | 26873969 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 ACACA PDE9A MYO5A TRPS1 ETV1 L2HGDH RTN3 ATP9B ZNF385B PTK2 SH3BP4 PTPN4 PHLDB1 PIP5K1A KDM6A POLG AFF3 GRIK2 FRYL CHST11 STK32C SHROOM2 TMEM255B RBM39 DNAH1 SHANK2 KIAA1217 RCOR3 PAN3 AFF4 | 2.19e-09 | 1489 | 211 | 31 | 28611215 |
| Pubmed | 6.55e-09 | 5 | 211 | 4 | 8397373 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | PALD1 IL16 IRAK2 ZNF385B PLXNA1 WDR44 SOX6 AFF3 CHST11 YES1 CTNND2 IL6ST EPHA8 | 1.03e-08 | 265 | 211 | 13 | 19240061 |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | PDE9A STRBP RTN3 P4HA3 ACTN2 ACVR1 PTK2 ST3GAL5 UCP3 HOMEZ IKZF3 NEBL LCP2 RBM39 TFDP1 CCND2 ARHGDIA CADPS RCOR3 TP53 | 3.27e-08 | 742 | 211 | 20 | 26871637 |
| Pubmed | 4.54e-08 | 7 | 211 | 4 | 12065756 | ||
| Pubmed | In silico prediction of physical protein interactions and characterization of interactome orphans. | 1.61e-07 | 136 | 211 | 9 | 25402006 | |
| Pubmed | The p53 tumor suppressor inhibits transcription of the TATA-less mouse DP1 promoter. | 2.20e-07 | 3 | 211 | 3 | 9556576 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | EPS8 ZSWIM8 STRBP NAGA ZNF385B PTK2 BHMT SYT11 TLN2 GNL1 GRIK2 RBM39 PPP2R1A CADPS HDLBP | 2.52e-07 | 475 | 211 | 15 | 31040226 |
| Pubmed | 2.69e-07 | 10 | 211 | 4 | 15611116 | ||
| Pubmed | Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP). | 2.69e-07 | 10 | 211 | 4 | 11266516 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PALD1 ACACA LYPLA2 DDB1 SCML2 AFG3L2 VDAC1 WDR44 UBFD1 GPI NEBL SH3GL1 RBM39 ARHGDIA KIAA1217 SCIN DEPDC1B TP53 AFF4 SON HDLBP | 3.02e-07 | 934 | 211 | 21 | 33916271 |
| Pubmed | BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo. | 4.20e-07 | 11 | 211 | 4 | 20406889 | |
| Pubmed | Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. | 4.20e-07 | 11 | 211 | 4 | 19758997 | |
| Pubmed | 4.59e-07 | 77 | 211 | 7 | 22973453 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | CEMIP2 SH3BP4 DIP2A PHLDB1 SYT11 PIP5K1A WDR44 YES1 CSPG4 LYN FYN DEPDC1B IL6ST | 6.10e-07 | 377 | 211 | 13 | 38117590 |
| Pubmed | ACACA INPPL1 DDB1 SH3BP4 BMP4 BMPR1A TEX264 AFG3L2 STOML2 GPI NEBL DCTN2 SH3GL1 SHC1 YES1 RBM39 DNAH1 PPP2R1A RCOR3 ARHGEF2 LYN FYN AFF4 HDLBP | 6.84e-07 | 1247 | 211 | 24 | 27684187 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 EPS8 ZSWIM8 RNGTT INPPL1 RTN3 DDX11 AFG3L2 IKZF3 PIAS2 PPP2R1A KIAA1217 SCIN TP53 SORL1 HDLBP | 7.22e-07 | 588 | 211 | 16 | 38580884 |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 19258394 | ||
| Pubmed | p21rasGAP association with Fyn, Lyn, and Yes in thrombin-activated platelets. | 8.77e-07 | 4 | 211 | 3 | 1544885 | |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 28232325 | ||
| Pubmed | B cell receptor signaling involves physical and functional association of FAK with Lyn and IgM. | 8.77e-07 | 4 | 211 | 3 | 11389892 | |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 22971142 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 11245687 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 16585062 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 22683331 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PALD1 ACACA INPPL1 PIEZO1 KDM6B SH3BP4 BMP4 DIP2A PHLDB1 SARS2 TLN2 PLXNA1 PLXNA3 POLG MTMR8 SHC1 FRYL STK32C SHANK2 CSPG4 ARHGEF2 CD276 | 1.18e-06 | 1105 | 211 | 22 | 35748872 |
| Pubmed | 1.26e-06 | 14 | 211 | 4 | 21791611 | ||
| Pubmed | 1.71e-06 | 15 | 211 | 4 | 10790433 | ||
| Pubmed | Integrin signalling regulates YAP and TAZ to control skin homeostasis. | 1.71e-06 | 15 | 211 | 4 | 26989177 | |
| Pubmed | 1.89e-06 | 34 | 211 | 5 | 25670795 | ||
| Pubmed | ACACA MYO5A RTN3 LRP1B DECR1 SYT11 AFG3L2 OSBPL8 TLN2 VDAC1 STOML2 HCN4 SH3GL1 SH3GL2 SHROOM2 RBM39 SHANK2 CADPS KIAA1217 CNTNAP2 CTNND2 HDLBP | 1.94e-06 | 1139 | 211 | 22 | 36417873 | |
| Pubmed | MYO5A TBC1D7 DDB1 PTK2 CNTNAP5 TLN2 STOML2 HCN4 SH3GL2 GRIK2 WDR91 PPP2R1A SHANK2 KIAA1217 CNKSR3 TMED9 FRMPD3 ARHGEF2 CTNND2 AFF4 | 1.98e-06 | 963 | 211 | 20 | 28671696 | |
| Pubmed | EPS8 ACACA INPPL1 CEMIP2 PHLDB1 ZFYVE9 SEMA6D AFG3L2 OSBPL8 PIP5K1A YES1 KIAA1217 DEPDC1B | 2.07e-06 | 421 | 211 | 13 | 36976175 | |
| Pubmed | Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases. | 2.18e-06 | 5 | 211 | 3 | 12846735 | |
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 10844001 | ||
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 11448999 | ||
| Pubmed | Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells. | 2.18e-06 | 5 | 211 | 3 | 22971575 | |
| Pubmed | BMPs and BMP receptors in mouse metanephric development: in vivo and in vitro studies. | 2.18e-06 | 5 | 211 | 3 | 12141440 | |
| Pubmed | KDM3A STRBP ACVR1 ACVR1B LRP1B PTK2 BMPR1A PIP5K1A PLXNA1 PLXNA3 MTMR8 CPNE5 YES1 CCND2 ADAMTS12 LYN FYN | 2.67e-06 | 730 | 211 | 17 | 34857952 | |
| Pubmed | ETV1 ACVR1 ACVR1B BMP4 HOXC5 SEMA6D PLXNA1 HOMEZ SOX6 PLXNA3 | 3.50e-06 | 251 | 211 | 10 | 29031500 | |
| Pubmed | RNF168 PSG5 EXPH5 DDB1 BMP4 ZFYVE9 KDM6A YES1 PIAS2 EPG5 PPP2R1A CSPG4 TP53 SON HDLBP | 3.78e-06 | 591 | 211 | 15 | 15231748 | |
| Pubmed | 3.82e-06 | 39 | 211 | 5 | 33580754 | ||
| Pubmed | Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. | 4.34e-06 | 6 | 211 | 3 | 10861086 | |
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 9837978 | ||
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 9774338 | ||
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 12923167 | ||
| Pubmed | Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. | 4.34e-06 | 6 | 211 | 3 | 8006002 | |
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 15998803 | ||
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 9799234 | ||
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 19420001 | ||
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 1381360 | ||
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 7516469 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PIEZO1 NAGA LAMA1 SLC38A5 RTN3 P4HA3 MAGT1 LRP1B DDB1 CEMIP2 GJA1 BMPR1A PLXNA1 PLXNA3 COL12A1 GRIK2 CSPG4 PAM TMED9 IL6ST CD276 SORL1 | 4.53e-06 | 1201 | 211 | 22 | 35696571 |
| Pubmed | 4.75e-06 | 19 | 211 | 4 | 28126904 | ||
| Pubmed | 4.75e-06 | 19 | 211 | 4 | 23616926 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PALD1 RTN3 MAGT1 DDB1 DECR1 DIP2A SARS2 CDC40 TEX264 AFG3L2 OSBPL8 MRPL24 GNL1 VDAC1 STOML2 WDR44 POLG SHC1 RBM39 MTFMT MTX2 KIAA1217 ARHGEF2 DEPDC1B SON | 4.89e-06 | 1496 | 211 | 25 | 32877691 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | EPS8 NOL4 KDM6B PTK2 PTPN4 AFG3L2 VDAC1 PLXNA3 DCTN2 SH3GL1 SH3GL2 SHC1 LCP2 ARHGDIA ARHGDIB PPP2R1A IGHM CTNND2 FYN TP53 EPHA8 | 5.60e-06 | 1124 | 211 | 21 | 21900206 |
| Pubmed | 5.63e-06 | 73 | 211 | 6 | 24728074 | ||
| Pubmed | The formation and function of the cardiac conduction system. | 7.27e-06 | 21 | 211 | 4 | 26786210 | |
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 10858437 | ||
| Pubmed | Proline-rich sequences that bind to Src homology 3 domains with individual specificities. | 7.57e-06 | 7 | 211 | 3 | 7536925 | |
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 12538589 | ||
| Pubmed | Specific interactions of neuronal focal adhesion kinase isoforms with Src kinases and amphiphysin. | 7.57e-06 | 7 | 211 | 3 | 12558988 | |
| Pubmed | Differential expression of BMP receptors in early mouse development. | 7.57e-06 | 7 | 211 | 3 | 9303341 | |
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 12588846 | ||
| Pubmed | QM, a putative tumor suppressor, regulates proto-oncogene c-yes. | 7.57e-06 | 7 | 211 | 3 | 12138090 | |
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 1715582 | ||
| Pubmed | 1.07e-05 | 23 | 211 | 4 | 20445055 | ||
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 15190072 | ||
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 21829547 | ||
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 20663871 | ||
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 7499252 | ||
| Pubmed | Phosphorylation of SOCS1 Inhibits the SOCS1-p53 Tumor Suppressor Axis. | 1.21e-05 | 8 | 211 | 3 | 31101761 | |
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 15671031 | ||
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 8702914 | ||
| Pubmed | Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis. | 1.21e-05 | 8 | 211 | 3 | 16921024 | |
| Pubmed | PDE9A TBC1D7 RTN3 P4HA3 ACTN2 GJA1 ZFYVE9 TEX264 SGF29 NPPB IKZF3 NEBL DCTN2 MTMR8 SHC1 LCP2 YES1 CCND2 ADAMTS12 PPP2R1A GTF2B ARHGEF2 FYN TP53 | 1.22e-05 | 1477 | 211 | 24 | 31515488 | |
| Pubmed | ZSWIM8 ACACA MYO5A STRBP DDB1 OSBPL8 VDAC1 STOML2 FRYL RBM39 ARHGDIA PPP2R1A TP53 SON HDLBP | 1.23e-05 | 653 | 211 | 15 | 22586326 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 ACACA EXPH5 L2HGDH MAGT1 DDB1 DIP2A PHLDB1 AFG3L2 OSBPL8 LCP2 RBM39 PPP2R1A | 1.24e-05 | 497 | 211 | 13 | 36774506 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | INPPL1 ACVR1 ACVR1B PTK2 BMPR1A AGO4 AFG3L2 OSBPL8 VAV3 GNL1 AFF3 SHC1 YES1 PPP2R1A ARHGEF2 LYN FYN AFF4 | 1.27e-05 | 910 | 211 | 18 | 36736316 |
| Pubmed | 1.27e-05 | 24 | 211 | 4 | 31581792 | ||
| Pubmed | 1.27e-05 | 24 | 211 | 4 | 25382630 | ||
| Pubmed | Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module. | 1.36e-05 | 177 | 211 | 8 | 22560297 | |
| Pubmed | Expression of Fgf and Tgfbeta signaling related genes during embryonic endochondral ossification. | 1.47e-05 | 51 | 211 | 5 | 15963767 | |
| Pubmed | 1.51e-05 | 25 | 211 | 4 | 16374509 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO5A STRBP DDB1 PHLDB1 AFG3L2 STOML2 GPI YES1 RBM39 ARHGDIA PPP2R1A TMED9 ARHGEF2 LYN SCIN FYN TP53 SON HDLBP | 1.75e-05 | 1024 | 211 | 19 | 24711643 |
| Pubmed | The TGFβ type I receptor TGFβRI functions as an inhibitor of BMP signaling in cartilage. | 1.77e-05 | 26 | 211 | 4 | 31311865 | |
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 23866081 | ||
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 22949634 | ||
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 9892651 | ||
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 20860622 | ||
| Pubmed | Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit. | 1.80e-05 | 9 | 211 | 3 | 18697750 | |
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 11732910 | ||
| Pubmed | Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. | 1.80e-05 | 9 | 211 | 3 | 12857866 | |
| Pubmed | 1.87e-05 | 134 | 211 | 7 | 24658140 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | EPS8 ACACA LRP1B DDB1 DECR1 DCTN2 SH3GL1 SH3GL2 YES1 RBM39 KIAA1217 SLC25A15 CNKSR3 PAN3 ARHGEF2 LYN TP53 | 2.02e-05 | 853 | 211 | 17 | 28718761 |
| Pubmed | 2.13e-05 | 55 | 211 | 5 | 15342483 | ||
| Interaction | RHOB interactions | PALD1 EPS8 INPPL1 SLC38A5 ACVR1B ADCY6 CEMIP2 SH3BP4 GJA1 DIP2A BMPR1A ZFYVE9 SEMA6D AFG3L2 OSBPL8 PIP5K1A PLXNA1 WDR44 SH3GL1 YES1 ARHGDIA PPP2R1A ARHGEF2 LYN FYN DEPDC1B IL6ST | 1.38e-07 | 840 | 206 | 27 | int:RHOB |
| Interaction | RAC3 interactions | EPS8 SLC38A5 CEMIP2 SH3BP4 GJA1 DIP2A BMPR1A AFG3L2 OSBPL8 PIP5K1A PLXNA1 FRYL YES1 ARHGDIA ARHGDIB PPP2R1A KIAA1217 LYN DEPDC1B IL6ST | 6.01e-06 | 619 | 206 | 20 | int:RAC3 |
| Interaction | CBLN4 interactions | 6.40e-06 | 127 | 206 | 9 | int:CBLN4 | |
| Interaction | ERBB2 interactions | INPPL1 ACVR1 PTK2 HCST GJA1 AFG3L2 VAV3 SH2D3C SHC1 LCP2 YES1 CCND2 AP3B2 ARHGEF2 LYN IL6ST TP53 SORL1 HDLBP | 1.06e-05 | 589 | 206 | 19 | int:ERBB2 |
| Interaction | BAMBI interactions | 1.33e-05 | 15 | 206 | 4 | int:BAMBI | |
| Interaction | IGSF1 interactions | 1.33e-05 | 15 | 206 | 4 | int:IGSF1 | |
| Interaction | GP6 interactions | 1.75e-05 | 16 | 206 | 4 | int:GP6 | |
| Interaction | PEX5L interactions | 1.82e-05 | 54 | 206 | 6 | int:PEX5L | |
| Interaction | LCP2 interactions | 2.03e-05 | 55 | 206 | 6 | int:LCP2 | |
| Interaction | ERBB4 interactions | 2.05e-05 | 184 | 206 | 10 | int:ERBB4 | |
| Interaction | FBXO2 interactions | PIEZO1 LAMA1 LRP1B CEMIP2 BMP4 OSBPL8 PLXNA1 PLXNA3 COL12A1 IGHM CSPG4 TMED9 IL6ST CD276 SORL1 | 2.29e-05 | 411 | 206 | 15 | int:FBXO2 |
| Interaction | PIK3R1 interactions | EPS8 INPPL1 PTK2 HCST GJA1 VAV3 IKZF3 SH3GL1 SHC1 LCP2 YES1 LYN FYN IL6ST EPHA8 | 2.35e-05 | 412 | 206 | 15 | int:PIK3R1 |
| Interaction | RAC1 interactions | PALD1 EPS8 STRBP INPPL1 SLC38A5 PTK2 CEMIP2 SH3BP4 GJA1 SEMA6D AFG3L2 OSBPL8 PIP5K1A VAV3 PLXNA1 YES1 RBM39 ARHGDIA ARHGDIB DSG4 ARHGEF2 LYN FYN DEPDC1B IL6ST HDLBP | 3.37e-05 | 1063 | 206 | 26 | int:RAC1 |
| Interaction | TSC2 interactions | 3.52e-05 | 196 | 206 | 10 | int:TSC2 | |
| Interaction | TEC interactions | 3.84e-05 | 90 | 206 | 7 | int:TEC | |
| Interaction | BECN1 interactions | 4.35e-05 | 201 | 206 | 10 | int:BECN1 | |
| Interaction | SUMO3 interactions | 4.66e-05 | 126 | 206 | 8 | int:SUMO3 | |
| Interaction | EPHA2 interactions | EPS8 ACACA INPPL1 PTK2 CEMIP2 GJA1 PHLDB1 ZFYVE9 SEMA6D AFG3L2 OSBPL8 PIP5K1A SHC1 YES1 CCND2 KIAA1217 LYN DEPDC1B TP53 EPHA8 | 5.12e-05 | 719 | 206 | 20 | int:EPHA2 |
| Interaction | RGMB interactions | 5.68e-05 | 8 | 206 | 3 | int:RGMB | |
| Interaction | RAC2 interactions | PALD1 RTN3 MAGT1 ACVRL1 CEMIP2 SH3BP4 GJA1 AFG3L2 OSBPL8 PIP5K1A TLN2 PLXNA1 YES1 ARHGDIA ARHGDIB LYN FYN DEPDC1B IL6ST | 6.66e-05 | 674 | 206 | 19 | int:RAC2 |
| Interaction | RHOU interactions | MYO5A ACVR1B CEMIP2 SH3BP4 GJA1 BMPR1A SYT11 AFG3L2 OSBPL8 PIP5K1A PLXNA1 YES1 TMEM255B LYN FYN DEPDC1B | 7.49e-05 | 510 | 206 | 16 | int:RHOU |
| Interaction | ERBB3 interactions | INPPL1 PTK2 VAV3 SH2D3C MTMR8 SHC1 LCP2 YES1 LYN IL6ST TP53 SORL1 EPHA8 | 7.83e-05 | 355 | 206 | 13 | int:ERBB3 |
| Interaction | HDAC4 interactions | EPS8 ZSWIM8 ACACA STRBP NAGA ZNF385B DDB1 PTK2 SYT11 TLN2 GNL1 NPPB IKZF3 SHC1 GRIK2 RBM39 PPP2R1A CADPS MEGF10 HDLBP | 8.19e-05 | 744 | 206 | 20 | int:HDAC4 |
| Interaction | CDC42 interactions | PALD1 ACACA RTN3 MAGT1 CEMIP2 SH3BP4 GJA1 BMPR1A FGD4 AFG3L2 OSBPL8 PLXNA1 VDAC1 FRYL YES1 RBM39 WDR91 ARHGDIA ARHGDIB PPP2R1A CSPG4 TMED9 LYN SCIN FYN DEPDC1B IL6ST TP53 HDLBP | 8.33e-05 | 1323 | 206 | 29 | int:CDC42 |
| Interaction | CBL interactions | EPS8 ACACA INPPL1 RTN3 DDB1 PTK2 DECR1 STOML2 SH3GL2 SHC1 LCP2 YES1 LYN FYN TP53 EPHA8 | 8.58e-05 | 516 | 206 | 16 | int:CBL |
| Interaction | KCTD13 interactions | EPS8 IL16 MYO5A RTN3 ACTN2 DDB1 GJA1 DIP2A PHLDB1 FGD4 AFG3L2 OSBPL8 TLN2 VDAC1 STOML2 GPI DCTN2 SH3GL1 SHROOM2 RBM39 ARHGDIA PPP2R1A SHANK2 CADPS KIAA1217 AP3B2 TMED9 ARHGEF2 CTNND2 HDLBP | 8.63e-05 | 1394 | 206 | 30 | int:KCTD13 |
| Interaction | SOCS1 interactions | 8.90e-05 | 177 | 206 | 9 | int:SOCS1 | |
| Interaction | RHOJ interactions | SLC38A5 ACVR1 ACVR1B ACVRL1 CEMIP2 SH3BP4 GJA1 DIP2A BMPR1A ZFYVE9 AFG3L2 OSBPL8 PIP5K1A PLXNA1 YES1 LYN DEPDC1B IL6ST | 9.34e-05 | 633 | 206 | 18 | int:RHOJ |
| Interaction | RAB25 interactions | LYPLA2 ACVR1 PTK2 CEMIP2 WDR44 SH3GL1 SHC1 YES1 ARHGDIA ARHGDIB IL6ST | 9.35e-05 | 265 | 206 | 11 | int:RAB25 |
| Interaction | RHOA interactions | PALD1 SYNPO2 STRBP SLC38A5 RTN3 MAGT1 CEMIP2 SH3BP4 GJA1 BMPR1A ZFYVE9 SEMA6D TEX264 AFG3L2 OSBPL8 VAV3 PLXNA1 IKZF3 FRYL YES1 ARHGDIA ARHGDIB ARHGEF2 LYN FYN DEPDC1B IL6ST | 9.61e-05 | 1199 | 206 | 27 | int:RHOA |
| Interaction | MCAM interactions | CEMIP2 SH3BP4 GJA1 DIP2A PHLDB1 SYT11 PIP5K1A VDAC1 WDR44 YES1 CSPG4 LYN FYN DEPDC1B IL6ST | 9.96e-05 | 468 | 206 | 15 | int:MCAM |
| Interaction | RHOC interactions | RNF168 ACVR1B ADCY6 CEMIP2 SH3BP4 GJA1 BMPR1A AFG3L2 OSBPL8 PLXNA1 YES1 ARHGDIA ARHGDIB LYN FYN DEPDC1B IL6ST | 1.11e-04 | 584 | 206 | 17 | int:RHOC |
| Interaction | CBLC interactions | 1.19e-04 | 75 | 206 | 6 | int:CBLC | |
| Interaction | CSF1R interactions | 1.19e-04 | 75 | 206 | 6 | int:CSF1R | |
| Interaction | RAB11A interactions | PALD1 MYO5A LYPLA2 RTN3 CEMIP2 ZFYVE9 TEX264 AFG3L2 OSBPL8 VDAC1 WDR44 DCTN2 SH3GL1 YES1 RBM39 ARHGDIA ARHGDIB PPP2R1A DEPDC1B IL6ST EPHA8 | 1.26e-04 | 830 | 206 | 21 | int:RAB11A |
| Interaction | DNAJC5 interactions | MYO5A PIEZO1 CEMIP2 SH3BP4 GJA1 NRXN3 AFG3L2 OSBPL8 PIP5K1A YES1 PPP2R1A CADPS DEPDC1B | 1.46e-04 | 378 | 206 | 13 | int:DNAJC5 |
| Interaction | LYN interactions | INPPL1 TFDP3 IRAK2 PTK2 CEMIP2 SH3BP4 BMPR1A AFG3L2 PIP5K1A PLXNA1 SH2D3C SHC1 LCP2 YES1 DUOXA1 KIAA1217 LYN DEPDC1B TP53 | 1.57e-04 | 720 | 206 | 19 | int:LYN |
| Interaction | TNIK interactions | MYO5A GJA1 DCTN2 SH3GL2 GRIK2 PPP2R1A SHANK2 KIAA1217 ARHGEF2 CTNND2 LYN TP53 HDLBP | 1.58e-04 | 381 | 206 | 13 | int:TNIK |
| Interaction | RHOG interactions | PALD1 ACACA LYPLA2 SLC38A5 MAGT1 CEMIP2 SH3BP4 DECR1 GJA1 AFG3L2 OSBPL8 PIP5K1A VAV3 MRPL24 PLXNA1 STOML2 POLG YES1 ARHGDIA DEPDC1B IL6ST TP53 | 1.66e-04 | 910 | 206 | 22 | int:RHOG |
| Interaction | HRAS interactions | EPS8 EXPH5 IRAK2 ADCY6 CEMIP2 BMPR1A PHLDB1 PIP5K1A PLXNA1 WDR44 IKZF3 SH3GL1 YES1 LYN FYN DEPDC1B TP53 CD276 HDLBP | 1.72e-04 | 725 | 206 | 19 | int:HRAS |
| Interaction | SHANK3 interactions | MYO5A RTN3 ACTN2 DDB1 PHLDB1 TLN2 VDAC1 STOML2 DCTN2 SH3GL2 FRYL STK32C SHANK2 MEGF10 TP53 | 1.88e-04 | 496 | 206 | 15 | int:SHANK3 |
| Interaction | HAVCR2 interactions | 2.08e-04 | 83 | 206 | 6 | int:HAVCR2 | |
| Interaction | PCDHGC3 interactions | 2.24e-04 | 54 | 206 | 5 | int:PCDHGC3 | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 1.25e-07 | 7 | 142 | 4 | 345 | |
| GeneFamily | SH2 domain containing | 1.30e-06 | 101 | 142 | 8 | 741 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.43e-05 | 24 | 142 | 4 | 485 | |
| GeneFamily | Transcription factor Dp family | 1.83e-04 | 3 | 142 | 2 | 987 | |
| GeneFamily | PDZ domain containing | 1.99e-04 | 152 | 142 | 7 | 1220 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 3.64e-04 | 4 | 142 | 2 | 1145 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 6.35e-04 | 50 | 142 | 4 | 1293 | |
| GeneFamily | Sterile alpha motif domain containing | 6.47e-04 | 88 | 142 | 5 | 760 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 2.13e-03 | 9 | 142 | 2 | 1280 | |
| GeneFamily | Plexins | 2.13e-03 | 9 | 142 | 2 | 683 | |
| GeneFamily | N-BAR domain containing | 3.84e-03 | 12 | 142 | 2 | 1289 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 NOL4 MYO5A ACVR1B LRP1B FAT2 NRXN3 SEMA6D ST3GAL5 PDXP TLN2 VAV3 PLXNA1 PLXNA3 IKZF3 AFF3 GRIK2 CHST11 CPNE5 SHROOM2 PIAS2 TTLL7 SHANK2 CADPS AP3B2 CNTNAP2 FRMPD3 CTNND2 SCIN | 1.84e-08 | 1106 | 209 | 29 | M39071 |
| Coexpression | DING_LUNG_CANCER_MUTATED_FREQUENTLY | 1.85e-06 | 12 | 209 | 4 | M16718 | |
| Coexpression | ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN | 4.34e-06 | 116 | 209 | 8 | M2222 | |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | MYO5A PIEZO1 BMPR1A AGO4 SYT11 PCBP4 CHST11 ARHGDIA CNKSR3 FYN | 4.62e-06 | 198 | 209 | 10 | M6511 |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 4.63e-06 | 117 | 209 | 8 | MM931 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 5.05e-06 | 200 | 209 | 10 | M8030 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP | 8.68e-06 | 168 | 209 | 9 | M8665 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | PALD1 PIEZO1 SLC38A5 ACVR1 MAGT1 ACVRL1 CEMIP2 SH3BP4 GJA1 BMP4 RAPGEF3 ICAM4 SH2D3C SHC1 LCP2 CPNE5 YES1 TMEM255B CREM PAM IL6ST | 9.58e-06 | 888 | 209 | 21 | M39049 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | ZSWIM8 TRPS1 NAGA ACVR1 KDM6B GPI PLXNA3 POLG RBM39 CSPG4 PAM PAN3 IL6ST SON | 2.00e-05 | 457 | 209 | 14 | M1613 |
| Coexpression | LIN_MELANOMA_COPY_NUMBER_UP | 2.41e-05 | 72 | 209 | 6 | M346 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | ZSWIM8 TRPS1 NAGA ACVR1 KDM6B GPI PLXNA3 POLG RBM39 CSPG4 PAM PAN3 IL6ST SON | 2.72e-05 | 470 | 209 | 14 | MM1053 |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 3.05e-05 | 75 | 209 | 6 | MM605 | |
| Coexpression | BCAT_BILD_ET_AL_DN | 3.23e-05 | 46 | 209 | 5 | M2702 | |
| Coexpression | GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN | 3.47e-05 | 200 | 209 | 9 | M4659 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN | 3.47e-05 | 200 | 209 | 9 | M7186 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN | 3.47e-05 | 200 | 209 | 9 | M3826 | |
| Coexpression | GSE3039_CD4_TCELL_VS_B2_BCELL_DN | 3.47e-05 | 200 | 209 | 9 | M6464 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 3.47e-05 | 200 | 209 | 9 | M5915 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 4.14e-05 | 116 | 209 | 7 | M2379 | |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_3D_DN | INPPL1 ACVRL1 CEMIP2 DDX11 NRXN3 VDAC1 HCN4 TMED9 SORL1 HDLBP | 5.18e-05 | 262 | 209 | 10 | M11472 |
| Coexpression | RODWELL_AGING_KIDNEY_UP | IL10RA PALD1 TREX1 IRAK2 HCST NRXN3 COL8A2 LCP2 CCND2 ARHGDIB SHANK2 IGHM PAM LYN | 5.43e-05 | 501 | 209 | 14 | M5389 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KDM3A EPS8 RNGTT TOGARAM1 ACVR1 PTK2 GJA1 PTPN4 BMPR1A ZFYVE9 ST3GAL5 OSBPL8 PIP5K1A FRYL RBM39 MTX2 LYN FYN SON | 6.07e-05 | 856 | 209 | 19 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HMGL | PALD1 IL16 INPPL1 PIEZO1 NAGA IRAK2 HCST CREM ARHGDIB PYCARD LYN SCIN IL6ST CDH17 SORL1 | 6.65e-05 | 577 | 209 | 15 | M39051 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 8.84e-05 | 176 | 209 | 8 | M39223 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | EPS8 ACVR1 VDAC1 GPI SHC1 LCP2 ARHGDIA PPP2R1A ARHGEF2 FYN SORL1 | 1.56e-04 | 359 | 209 | 11 | M15193 |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | SYNPO2 MYO5A NUP210L STRBP TRPS1 PTK2 DIP2A UCP3 VAV3 PLXNA3 NEBL AFF3 SHROOM2 CREM SHANK2 PYCARD CTNND2 | 2.03e-04 | 786 | 209 | 17 | M10961 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP | 2.06e-04 | 199 | 209 | 8 | M7712 | |
| Coexpression | GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN | 2.13e-04 | 200 | 209 | 8 | M5966 | |
| Coexpression | GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP | 2.13e-04 | 200 | 209 | 8 | M8038 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 2.13e-04 | 200 | 209 | 8 | M8081 | |
| Coexpression | GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP | 2.13e-04 | 200 | 209 | 8 | M7489 | |
| Coexpression | GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP | 2.13e-04 | 200 | 209 | 8 | M7490 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 2.13e-04 | 200 | 209 | 8 | M6513 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN | 2.13e-04 | 200 | 209 | 8 | M9262 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | KDM3A MYO5A EXPH5 TOGARAM1 ACVR1 ACVR1B SEMA6D ST3GAL5 SYT11 OSBPL8 NEBL SH3GL2 RCAN3 TTLL7 CADPS RCOR3 FYN AFF4 SORL1 | 2.21e-04 | 946 | 209 | 19 | M39169 |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | ZNF385B ACTN2 NPPB NRAP NEBL AFF3 CPNE5 CADPS CNKSR3 PAM CTNND2 MYBPC3 | 1.08e-10 | 188 | 210 | 12 | 6d249fe92d51a19da19ec14bb2262d394255d577 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | STRBP RTN3 ZNF385B CNTNAP5 NRXN3 SH3GL2 AFF3 GRIK2 SHANK2 CADPS CNTNAP2 PAM | 1.97e-10 | 198 | 210 | 12 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | ZNF385B ACTN2 NPPB NRAP NEBL GRIK2 CPNE5 CADPS CNKSR3 PAM MYBPC3 | 2.30e-09 | 194 | 210 | 11 | 89812fb164065041357bb37a3c2d87028ec3de4e |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | STRBP RTN3 ZNF385B CNTNAP5 NRXN3 SH3GL2 AFF3 GRIK2 SHANK2 CADPS CNTNAP2 | 2.85e-09 | 198 | 210 | 11 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | BDP1 STRBP RTN3 ZNF385B NRXN3 SH3GL2 AFF3 GRIK2 SHANK2 CADPS CNTNAP2 | 3.16e-09 | 200 | 210 | 11 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-08 | 181 | 210 | 10 | a6c8b33a392de3df2f179317e329e45d3d8c6f52 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | PALD1 ACVRL1 CEMIP2 PHLDB1 NRXN3 AFF3 SH2D3C SHROOM2 KIAA1217 FYN | 2.29e-08 | 188 | 210 | 10 | 02a62888e9db29d20133eeca1686d302545a39c9 |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-08 | 189 | 210 | 10 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Control-Lymphoid-NK|World / Disease state, Lineage and Cell class | 2.41e-08 | 189 | 210 | 10 | 89ef0d0e66dc96cacaae6be7aacdaa884e8e66a8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | EXPH5 LAMA1 NRXN3 ST3GAL5 FGD4 VAV3 SH3GL2 SHANK2 CTNND2 SORL1 | 2.53e-08 | 190 | 210 | 10 | 625c08a0e5227efc46daa512fd579c3938ff76c7 |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.66e-08 | 191 | 210 | 10 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | IL16 ZNF385B SOX6 COL8A2 MXRA5 COL12A1 GRIK2 CHST11 CSPG4 SCIN | 2.80e-08 | 192 | 210 | 10 | 3a6f2c255da46a0b0f5b657b0f56f3d7798ae85a |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 2.94e-08 | 193 | 210 | 10 | a98ee519e0da93ae4a2dcdda1ee8b4138dec131b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | STRBP RTN3 ZNF385B NRXN3 SH3GL2 AFF3 GRIK2 SHANK2 CADPS CNTNAP2 | 3.40e-08 | 196 | 210 | 10 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | STRBP RTN3 ZNF385B NRXN3 OSBPL8 AFF3 GRIK2 SHANK2 CADPS CNTNAP2 | 3.74e-08 | 198 | 210 | 10 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | EPS8 ACACA STRBP EXPH5 ZNF385B FGD4 NEBL SHANK2 DUOXA1 KIAA1217 | 3.93e-08 | 199 | 210 | 10 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.93e-08 | 199 | 210 | 10 | e245851a5bddf56f7e13a7fb7c5fda2fd275dae3 | |
| ToppCell | distal-2-Hematologic-Natural_Killer|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.93e-08 | 199 | 210 | 10 | 77cc79c612c56022b37c8f690363c9ac8776e9cf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.93e-08 | 199 | 210 | 10 | e7faf7d0cb43cf93149c446e5f718f84fa85477c | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.11e-08 | 200 | 210 | 10 | 44674ccfd1ad4ac45968484d70220bc0506e2651 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.11e-08 | 200 | 210 | 10 | b5d00efb4286ae63cb081ef774aa0b0ff90d6c8a | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-07 | 174 | 210 | 9 | 5b00a795a9dd1a77305fcac5017cb276afdc1a27 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-07 | 174 | 210 | 9 | 3340b44c77f55244e3c2e2ea479d42563f937040 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-07 | 179 | 210 | 9 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.98e-07 | 180 | 210 | 9 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | RA-17._Lymphocyte|World / Chamber and Cluster_Paper | 2.28e-07 | 183 | 210 | 9 | 6397f684a50346fc42cccb5afbe10350f4b2d9b0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.74e-07 | 187 | 210 | 9 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 3.00e-07 | 189 | 210 | 9 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.28e-07 | 191 | 210 | 9 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | IPF-Lymphoid-NK|World / Disease state, Lineage and Cell class | 3.28e-07 | 191 | 210 | 9 | f206159b9d5e84cf14a65bfdc008895cec5a8081 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.28e-07 | 191 | 210 | 9 | f9a46956778a8773d6656340ecf5d218376d79c2 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.42e-07 | 192 | 210 | 9 | a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.58e-07 | 193 | 210 | 9 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-07 | 193 | 210 | 9 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.58e-07 | 193 | 210 | 9 | b52d5661edff83ac4c5fe2bf89d6672016bb827b | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.73e-07 | 194 | 210 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 3.73e-07 | 194 | 210 | 9 | 3337042eef91a49f621058785723228cf4dfdad4 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.90e-07 | 195 | 210 | 9 | 0a72b8446399807ace5b6c72f865bb40dbd9e92d | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PALD1 PIEZO1 ACVRL1 GJA1 VAV3 SH2D3C CPNE5 TMEM255B ADAMTS12 | 4.07e-07 | 196 | 210 | 9 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PALD1 PIEZO1 ACVRL1 GJA1 VAV3 SH2D3C CPNE5 TMEM255B ADAMTS12 | 4.07e-07 | 196 | 210 | 9 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | ACVRL1 CEMIP2 NRXN3 AFF3 SH2D3C SHROOM2 TMEM255B KIAA1217 FYN | 4.07e-07 | 196 | 210 | 9 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.43e-07 | 198 | 210 | 9 | 1e43181c13e054570046c7a973ddc1c586e259b0 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-07 | 198 | 210 | 9 | 7608f67959e1cda7b10e57fd3af2f96216ebe7e9 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.43e-07 | 198 | 210 | 9 | c54da37aa11f82a68e591d563b3db9121d6b498f | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.43e-07 | 198 | 210 | 9 | 58d805e827299292750b09c6283fdbe406b75f79 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.43e-07 | 198 | 210 | 9 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.43e-07 | 198 | 210 | 9 | 90023468f3498548a92d75928f476b4157bde813 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-07 | 198 | 210 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-07 | 198 | 210 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.62e-07 | 199 | 210 | 9 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | medial-2-Hematologic-Natural_Killer|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.62e-07 | 199 | 210 | 9 | 52338b8970fba0b32578748ba0bec0b344171ca6 | |
| ToppCell | medial-Hematologic-Natural_Killer-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.62e-07 | 199 | 210 | 9 | dfcc4976688c7e6df5e41ae77436710075f1f779 | |
| ToppCell | Caecum-(1)_T_cell-(15)_Treg|Caecum / shred on region, Cell_type, and subtype | 4.62e-07 | 199 | 210 | 9 | 12c22b07a231c9dc548e9dc37e0a60296a4a6273 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-07 | 199 | 210 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Caecum-T_cell-Treg|Caecum / Region, Cell class and subclass | 4.62e-07 | 199 | 210 | 9 | ab0b32c077ac26d32a293dcf686af6984980793f | |
| ToppCell | medial-Hematologic-Natural_Killer|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.62e-07 | 199 | 210 | 9 | 4a75ef6a3b7b5d779a08d039a79322cd60b4ef65 | |
| ToppCell | Sigmoid-(1)_T_cell-(17)_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 4.82e-07 | 200 | 210 | 9 | a02e5a69f7101accd8f1394ab1c8007e211187f7 | |
| ToppCell | Sigmoid-T_cell-gd_T|Sigmoid / Region, Cell class and subclass | 4.82e-07 | 200 | 210 | 9 | eef4df008cccdf6297b1c90c986c68793afd8b78 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.82e-07 | 200 | 210 | 9 | 72e1cc0b222df3ab76164524676e91628e237995 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-BMP_responsible_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.82e-07 | 200 | 210 | 9 | cd0d69f973ca3204b500d12031b403a1f4593431 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 171 | 210 | 8 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.96e-06 | 176 | 210 | 8 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | facs-Liver-Non-hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 177 | 210 | 8 | f73ed860685a724591d0f543a9ac4e868aff92f5 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 177 | 210 | 8 | 6d86b2f97426b552dff5ce6ddf0ead1285ed618e | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 177 | 210 | 8 | d8b1bbc224d062a57a6ad40b4b2af5d6e0fe63b3 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 179 | 210 | 8 | f4fd214a9865c635d8a744ce5e0eff45174d3de4 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.22e-06 | 179 | 210 | 8 | ac0c257e63a5994282d8b350c1b517cc3fbee52a | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 179 | 210 | 8 | 57d8d44a793314eec8f77030f4177bfe21d41652 | |
| ToppCell | facs-BAT-Fat-18m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 182 | 210 | 8 | efc335f4e566533cfbcd17262bd94ae64fa2e117 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 2.62e-06 | 183 | 210 | 8 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.73e-06 | 184 | 210 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 2.73e-06 | 184 | 210 | 8 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.84e-06 | 185 | 210 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Control-Lymphocytic_NKT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-06 | 185 | 210 | 8 | 59d68e119f58b35bab36294758f6b2e25fd8f5c0 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.84e-06 | 185 | 210 | 8 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Treg|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.84e-06 | 185 | 210 | 8 | c1a44b7eed72a673923a7c44d06f891f18aa5aad | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 186 | 210 | 8 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 186 | 210 | 8 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 186 | 210 | 8 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.07e-06 | 187 | 210 | 8 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 3.07e-06 | 187 | 210 | 8 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.20e-06 | 188 | 210 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 3.20e-06 | 188 | 210 | 8 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 3.33e-06 | 189 | 210 | 8 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.33e-06 | 189 | 210 | 8 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 3.33e-06 | 189 | 210 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | IPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class | 3.33e-06 | 189 | 210 | 8 | d92e880162450f8d01e4b8784eb625275cb8e03e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-06 | 189 | 210 | 8 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-06 | 190 | 210 | 8 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 3.46e-06 | 190 | 210 | 8 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | Control-Lymphoid-NK|Control / Disease state, Lineage and Cell class | 3.46e-06 | 190 | 210 | 8 | f7bd8521a40ac30a64dc439f17e2f6c7d021ef65 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-06 | 190 | 210 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.60e-06 | 191 | 210 | 8 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-06 | 191 | 210 | 8 | 753deb090b7b78b4ef31604dbe5dbfc4dcf5184a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-06 | 191 | 210 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-06 | 191 | 210 | 8 | 337d7d7b89fe370e1fe005b9daad76c5dc3b8444 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-06 | 191 | 210 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-06 | 191 | 210 | 8 | 355f5bcb220d917163833dead0050fc756c7b260 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.60e-06 | 191 | 210 | 8 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.74e-06 | 192 | 210 | 8 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| Drug | atremon | 4.74e-07 | 33 | 207 | 6 | CID000002741 | |
| Drug | polyoxyethylene (10 | 1.67e-06 | 63 | 207 | 7 | CID000079689 | |
| Drug | imatinib | INPPL1 LAMA1 ACVR1 ACVR1B ACVRL1 PTK2 BMPR1A NPPB YES1 CCND2 ARHGEF2 LYN FYN IL6ST TP53 EPHA8 | 2.21e-06 | 430 | 207 | 16 | CID000005291 |
| Drug | AC1L1F9T | 7.31e-06 | 5 | 207 | 3 | CID000003145 | |
| Drug | 5'-hydroxyaverantin | 7.31e-06 | 5 | 207 | 3 | CID000126118 | |
| Drug | geldanamycin | BDP1 RNGTT MYO5A PTK2 DIP2A OSBPL8 KDM6A COL12A1 AFF3 FRYL CCND2 IL6ST TP53 AFF4 | 8.28e-06 | 371 | 207 | 14 | ctd:C001277 |
| Drug | Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; PC3; HT_HG-U133A | 1.37e-05 | 197 | 207 | 10 | 4555_UP | |
| Drug | averufin | 1.45e-05 | 6 | 207 | 3 | CID000131171 | |
| Drug | averufanin | 1.45e-05 | 6 | 207 | 3 | CID000119255 | |
| Drug | Scopoletin [92-61-5]; Up 200; 20.8uM; HL60; HT_HG-U133A | TFDP3 TLN2 PLXNA3 DCTN2 GRIK2 CREM TTLL7 ADAMTS12 CTNND2 SCIN | 1.56e-05 | 200 | 207 | 10 | 3131_UP |
| Drug | polyproline | EPS8 TREX1 MYO5A IRAK2 SH3GL2 LCP2 YES1 SHANK2 CTNND2 LYN FYN TP53 | 1.77e-05 | 295 | 207 | 12 | CID000439587 |
| Drug | sodium;hexadecane | 1.77e-05 | 36 | 207 | 5 | CID000172416 | |
| Drug | averantin | 2.52e-05 | 7 | 207 | 3 | CID000022049 | |
| Drug | AC1N4UEG | 2.87e-05 | 20 | 207 | 4 | CID004184747 | |
| Drug | Methamphetamine | NUP210L INPPL1 SLC38A5 IRAK2 SPAG8 ACVRL1 KDM6B ADCY6 PHLDB1 CNTNAP5 SARS2 RAPGEF3 PIP5K1A PCBP4 KDM6A VDAC1 NPY2R HCN4 SH3GL1 SH3GL2 SH2D3C CREM DNAH1 ARHGDIA PYCARD ARHGEF2 FYN TP53 MYBPC3 | 2.90e-05 | 1401 | 207 | 29 | ctd:D008694 |
| Disease | Epilepsy, Cryptogenic | 2.23e-05 | 82 | 203 | 6 | C0086237 | |
| Disease | Awakening Epilepsy | 2.23e-05 | 82 | 203 | 6 | C0751111 | |
| Disease | Aura | 2.23e-05 | 82 | 203 | 6 | C0236018 | |
| Disease | FEV/FEC ratio | PDE9A STRBP TRPS1 ETV1 ACVR1 ACVR1B PTK2 CEMIP2 GJA1 BMP4 PTPN4 HOXC5 DTHD1 NEBL AFF3 MTFMT CADPS CSPG4 CNTNAP2 CD276 SORL1 HDLBP | 4.24e-05 | 1228 | 203 | 22 | EFO_0004713 |
| Disease | fibrodysplasia ossificans progressiva (implicated_via_orthology) | 4.71e-05 | 2 | 203 | 2 | DOID:13374 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | TRPS1 ZNF385B KDM6B FAM186B GJA1 DIP2A TLN2 HOMEZ SOX6 NPPB MXRA5 NEBL FRYL CHST11 CPNE5 YES1 CCND2 GTF2B KIAA1217 CTNND2 TP53 CDH17 MYBPC3 | 9.59e-05 | 1392 | 203 | 23 | EFO_0005763 |
| Disease | Epilepsy | 1.11e-04 | 109 | 203 | 6 | C0014544 | |
| Disease | Colorectal Carcinoma | ACACA LAMA1 ETV1 CLSTN2 BMP4 BMPR1A KDM6A STK32C CCND2 GTF2B PYCARD CTNND2 IL6ST TP53 SORL1 | 1.14e-04 | 702 | 203 | 15 | C0009402 |
| Disease | Kabuki syndrome (implicated_via_orthology) | 1.41e-04 | 3 | 203 | 2 | DOID:0060473 (implicated_via_orthology) | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 1.41e-04 | 3 | 203 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | cognitive function measurement | IL10RA SYNPO2 NUP210L PIEZO1 CLSTN2 FAM186B LRP1B PTK2 CNTNAP5 NRXN3 SEMA6D FGD4 VAV3 A1CF AFF3 TTLL7 KIAA1217 AP3B2 CNKSR3 CTNND2 FYN CDH17 MYBPC3 | 1.48e-04 | 1434 | 203 | 23 | EFO_0008354 |
| Disease | ischemia (biomarker_via_orthology) | 2.43e-04 | 18 | 203 | 3 | DOID:326 (biomarker_via_orthology) | |
| Disease | Cardiomyopathies | 2.89e-04 | 130 | 203 | 6 | C0878544 | |
| Disease | total blood protein measurement | ZSWIM8 RNF168 SLC38A5 CEMIP2 VDAC1 IKZF3 A1CF AFF3 DNAH1 CCND2 HDLBP | 3.02e-04 | 449 | 203 | 11 | EFO_0004536 |
| Disease | activities of daily living score measurement | 3.89e-04 | 21 | 203 | 3 | EFO_0008451 | |
| Disease | Carcinoma of pancreas | 4.65e-04 | 5 | 203 | 2 | cv:C0235974 | |
| Disease | cerebellar ataxia (is_implicated_in) | 4.65e-04 | 5 | 203 | 2 | DOID:0050753 (is_implicated_in) | |
| Disease | Carcinoma of lung | 5.13e-04 | 23 | 203 | 3 | C0684249 | |
| Disease | Adenoid Cystic Carcinoma | 6.51e-04 | 100 | 203 | 5 | C0010606 | |
| Disease | mental development measurement | 6.60e-04 | 25 | 203 | 3 | EFO_0008230 | |
| Disease | tongue squamous cell carcinoma (biomarker_via_orthology) | 6.94e-04 | 6 | 203 | 2 | DOID:0050865 (biomarker_via_orthology) | |
| Disease | amyloid-beta measurement | 8.36e-04 | 355 | 203 | 9 | EFO_0005194 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 9.26e-04 | 28 | 203 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | biological sex | 1.12e-03 | 230 | 203 | 7 | PATO_0000047 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.14e-03 | 30 | 203 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | susceptibility to hepatitis A infection measurement | 1.26e-03 | 68 | 203 | 4 | EFO_0008415 | |
| Disease | QT interval, response to tricyclic antidepressant | 1.28e-03 | 8 | 203 | 2 | EFO_0004682, EFO_0007916 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.28e-03 | 8 | 203 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | coronary restenosis (is_implicated_in) | 1.28e-03 | 8 | 203 | 2 | DOID:4247 (is_implicated_in) | |
| Disease | Rheumatoid Arthritis | 1.34e-03 | 174 | 203 | 6 | C0003873 | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.37e-03 | 32 | 203 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | prostate cancer (implicated_via_orthology) | 1.50e-03 | 33 | 203 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 1.55e-03 | 72 | 203 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | melanoma (is_implicated_in) | 1.64e-03 | 34 | 203 | 3 | DOID:1909 (is_implicated_in) | |
| Disease | Carcinoma, Small Cell | 1.64e-03 | 9 | 203 | 2 | C0262584 | |
| Disease | hoarding disorder | 1.94e-03 | 36 | 203 | 3 | EFO_0803361 | |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 2.04e-03 | 10 | 203 | 2 | EFO_1000650, HP_0000131 | |
| Disease | 3-phenylpropionate hydrocinnamate measurement | 2.04e-03 | 10 | 203 | 2 | EFO_0021010 | |
| Disease | Small Lymphocytic Lymphoma | 2.04e-03 | 10 | 203 | 2 | C0855095 | |
| Disease | B-CELL MALIGNANCY, LOW-GRADE | 2.04e-03 | 10 | 203 | 2 | C1868683 | |
| Disease | gut microbiome measurement, bone density | 2.09e-03 | 78 | 203 | 4 | EFO_0003923, EFO_0007874 | |
| Disease | dilated cardiomyopathy (is_marker_for) | 2.44e-03 | 39 | 203 | 3 | DOID:12930 (is_marker_for) | |
| Disease | Macrocephaly | 2.49e-03 | 11 | 203 | 2 | C0221355 | |
| Disease | response to radiation, breast carcinoma | 2.49e-03 | 11 | 203 | 2 | EFO_0000305, GO_0009314 | |
| Disease | visual epilepsy (is_implicated_in) | 2.49e-03 | 11 | 203 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 2.49e-03 | 11 | 203 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | Cardiomegaly | 2.50e-03 | 82 | 203 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 2.50e-03 | 82 | 203 | 4 | C1383860 | |
| Disease | sudden cardiac arrest | 2.62e-03 | 83 | 203 | 4 | EFO_0004278 | |
| Disease | Alcoholic Intoxication, Chronic | 2.65e-03 | 268 | 203 | 7 | C0001973 | |
| Disease | Giant Cell Glioblastoma | 2.73e-03 | 84 | 203 | 4 | C0334588 | |
| Disease | lymphocyte count | PALD1 IL16 ACACA STRBP EXPH5 PIEZO1 TBC1D7 ETV1 ACVRL1 DIP2A PTPN4 ST3GAL5 SYT11 GNL1 IKZF3 PCDHGB6 PCDHGB3 PCDHGB2 CCND2 GTF2B | 2.80e-03 | 1464 | 203 | 20 | EFO_0004587 |
| Disease | kidney disease (implicated_via_orthology) | 2.82e-03 | 41 | 203 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | response to anticonvulsant | 2.85e-03 | 85 | 203 | 4 | GO_0036277 | |
| Disease | p-cresol glucuronide measurement | 2.97e-03 | 12 | 203 | 2 | EFO_0800079 | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 2.97e-03 | 12 | 203 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | high grade glioma (is_implicated_in) | 3.02e-03 | 42 | 203 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | oral microbiome measurement | 3.02e-03 | 42 | 203 | 3 | EFO_0801229 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 3.02e-03 | 42 | 203 | 3 | DOID:612 (is_implicated_in) | |
| Disease | Colorectal Neoplasms | 3.18e-03 | 277 | 203 | 7 | C0009404 | |
| Disease | Familial dilated cardiomyopathy | 3.45e-03 | 44 | 203 | 3 | C0340427 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 3.49e-03 | 13 | 203 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Cardiotoxicity | 3.49e-03 | 13 | 203 | 2 | C0876994 | |
| Disease | putamen volume change measurement | 3.49e-03 | 13 | 203 | 2 | EFO_0021495 | |
| Disease | obesity (is_implicated_in) | 3.65e-03 | 91 | 203 | 4 | DOID:9970 (is_implicated_in) | |
| Disease | hair colour measurement | IL16 PIEZO1 TRPS1 ETV1 L2HGDH DDX11 SEMA6D PLXNA1 SOX6 EPG5 ADAMTS12 | 3.73e-03 | 615 | 203 | 11 | EFO_0007822 |
| Disease | Prostatic Neoplasms | 3.77e-03 | 616 | 203 | 11 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.77e-03 | 616 | 203 | 11 | C0376358 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | KDM3A ACTN2 FAM186B PTK2 CEMIP2 CNTNAP5 NRXN3 SEMA6D NRAP AFF3 STK32C CD276 SORL1 | 3.82e-03 | 801 | 203 | 13 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Intellectual Disability | 3.97e-03 | 447 | 203 | 9 | C3714756 | |
| Disease | asymmetric dimethylarginine measurement | 4.06e-03 | 14 | 203 | 2 | EFO_0010463 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.10e-03 | 152 | 203 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cannabis dependence measurement | 4.42e-03 | 48 | 203 | 3 | EFO_0008457 | |
| Disease | Paroxysmal atrial fibrillation | 4.58e-03 | 156 | 203 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 4.58e-03 | 156 | 203 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.58e-03 | 156 | 203 | 5 | C2585653 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 4.66e-03 | 15 | 203 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | heart rate | 4.79e-03 | 225 | 203 | 6 | EFO_0004326 | |
| Disease | mean platelet volume | MYO5A NUP210L ACVRL1 ST3GAL5 FGD4 HOMEZ GLOD5 PCDHGB6 PCDHGB3 PCDHGB2 AFF3 FRYL CPNE5 LYN MYBPC3 | 4.84e-03 | 1020 | 203 | 15 | EFO_0004584 |
| Disease | Atrial Fibrillation | 5.09e-03 | 160 | 203 | 5 | C0004238 | |
| Disease | idiopathic osteonecrosis of the femoral head | 5.53e-03 | 52 | 203 | 3 | EFO_1001930 | |
| Disease | alcohol consumption measurement | ACACA TRPS1 P4HA3 CNTNAP5 NRXN3 SEMA6D SGF29 COL12A1 AFF3 CPNE5 CADPS CNKSR3 RCOR3 CTNND2 AFF4 SORL1 MYBPC3 | 5.64e-03 | 1242 | 203 | 17 | EFO_0007878 |
| Disease | major depressive disorder (is_implicated_in) | 5.98e-03 | 17 | 203 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | Metastatic melanoma | 6.15e-03 | 54 | 203 | 3 | C0278883 | |
| Disease | borna disease (biomarker_via_orthology) | 6.70e-03 | 18 | 203 | 2 | DOID:5154 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TQGSDPYIKMTILPD | 191 | Q9BT88 | |
| MAVPPTYADLGKSAR | 1 | P21796 | |
| TIIPKVLAMSGDPNY | 481 | P30153 | |
| GRQALVVGKPSPYMF | 586 | Q6ZT62 | |
| RIASGRPYNPSMSKP | 356 | Q93088 | |
| LVQQKPTAYVRPMDG | 226 | P51826 | |
| YAMRLKTHSGPNATP | 1041 | P51826 | |
| YQAVRAEPTNPSKMR | 146 | Q9ULZ3 | |
| AKGDYLPETTRPQEM | 596 | Q9HCE0 | |
| ENKPYVPSSAQMTRR | 1666 | A6H8Y1 | |
| NTPKPDERAIMTYVS | 236 | P35609 | |
| FSVKSPPSAGYLVMV | 1276 | Q6UVK1 | |
| APSVREIYMNVPVGA | 376 | Q9NQ94 | |
| DLPRQGDMVLEKPYS | 676 | Q9Y4W6 | |
| CPAAGRVALKYMTPV | 886 | O43306 | |
| PNQRVGTKRYMAPEV | 371 | P36896 | |
| YNRMDPRAQTPVPGK | 446 | Q92974 | |
| GERTPAAVEKRGPYM | 46 | Q5XKK7 | |
| AAVEKRGPYMVTRAP | 51 | Q5XKK7 | |
| RGPYMVTRAPSIQAK | 56 | Q5XKK7 | |
| GNNPRVGTKRYMAPE | 371 | Q04771 | |
| RRMVSNGIVEDYKPP | 416 | Q04771 | |
| PSVMRSPSAGKLIQY | 751 | Q13085 | |
| NNPRVGTKRYMAPEV | 366 | P37023 | |
| IRMPGVTPKQSDTYF | 61 | P19021 | |
| SMGKASPPYDVQIVD | 391 | Q6NUN0 | |
| IYSSPGVMLPKQDFV | 116 | P43155 | |
| KYPGADMDITLSAPS | 416 | Q8WUY9 | |
| AVSLQVAAPYSKPSM | 351 | Q5ZPR3 | |
| GKQRPMSSVEFTYRP | 606 | Q8IYM0 | |
| RLVKSNSMVGGPDPY | 371 | Q9HCK5 | |
| PAPMLQYGGRNKTVA | 406 | Q9HCK5 | |
| MADPKYADLPGIARN | 1 | Q13561 | |
| KRIEYQPGSGSMPLF | 266 | Q9H4D0 | |
| PQPSKSAVIPDYMRD | 71 | P12644 | |
| DRVYQKPPMRSLSQS | 426 | Q9UQB3 | |
| TPFYNTLTKGPEMEI | 1141 | P58397 | |
| GRYVVAGKMSISPNT | 601 | Q76LX8 | |
| QKPTAYVRPMDGQES | 251 | Q9UHB7 | |
| AAAAAPSRKPYVMDP | 286 | Q13367 | |
| MSGEVRDKSYLLPPQ | 126 | Q9UKA8 | |
| RPPKGMYLTQEDVVA | 216 | Q9P2K3 | |
| FAGKMITAAYVPLPT | 496 | Q14498 | |
| EEIRKIPMFSSYNPG | 291 | Q96IZ5 | |
| YDQKMPVIVSRVAPG | 536 | P29074 | |
| EMKVEQYGPQTTPRG | 16 | P49146 | |
| DMVPRSAEPGYLVTK | 576 | Q9Y5F9 | |
| SPSSPLYRMKSGNRV | 446 | Q7Z4N8 | |
| RMPIYGTAQPSAKAL | 511 | Q9ULE6 | |
| MNYLDRFLAGVPTPK | 81 | P30279 | |
| MKSPARRDSPYAEIN | 1051 | Q96KG7 | |
| ASKYVDVPKPGMDVA | 1216 | Q9ULU8 | |
| KTRMYSLRPEPPNTG | 636 | Q5HY64 | |
| PPGLAAYTAKMAAAN | 376 | P57723 | |
| QAYGSRAPTVHEMPK | 61 | Q5BN46 | |
| QDKTGTVPRVPYFAM | 126 | A6NJV1 | |
| PGMYSQKAARPALEE | 96 | Q00444 | |
| AGEPYAIAVNPKRGM | 4026 | Q9NZR2 | |
| KAPPRNYSVIVMFTA | 66 | Q9H0U3 | |
| PLKTMLGPRYDSQVA | 26 | O60942 | |
| GIPAMDNNRSPVYLK | 411 | O43187 | |
| YEQPRGKGSFPAMIT | 161 | Q86VF7 | |
| KESPSRSIDGMQYPI | 226 | Q9H9P8 | |
| PGSQFMYVVDTRPKL | 231 | Q96EF0 | |
| PRTGAKGPIMSIYFR | 131 | A6NK44 | |
| MADQIPLYPVRSAAA | 1 | O43861 | |
| TVQLYMKVPGSRTPG | 1131 | O15550 | |
| VQLYMKVPGSRTPGH | 1376 | O15054 | |
| YKIVSQEPSGAPMFI | 196 | Q86SJ6 | |
| KGVPYSQRPKAADMD | 1541 | Q9UIW2 | |
| KGIPYSQRPKAEDMD | 1516 | P51805 | |
| PYKAVLTENMPVGTS | 2801 | Q9NYQ8 | |
| DMVPRAAEPGYLVTK | 576 | Q9Y5G2 | |
| TMPANSERTPYKVRP | 66 | O76083 | |
| VSAYDQKPQVGMRPS | 121 | P50549 | |
| MYGAPQDVRAQATIP | 676 | Q96M96 | |
| MSNITIDPDVKPGEY | 1 | O94915 | |
| SKEDGMPVPELYNRI | 61 | Q8N743 | |
| APISTAKPNYRIMVE | 341 | Q14005 | |
| SGELQPQRPYMDVVS | 131 | Q9Y4C0 | |
| GSELKAMVQAPPGYT | 871 | P54098 | |
| PMPVRGAAVQAKIYN | 156 | Q8NEV8 | |
| PGTAPKLMIYEVSNR | 61 | A0A075B6J9 | |
| KLMIYEVSNRPSGVP | 66 | A0A075B6J9 | |
| MVTEALKPYSSGGPR | 166 | P06744 | |
| MEPTGPTQERYKDGV | 346 | P36915 | |
| PRPKMAPANDTYESI | 146 | Q13651 | |
| PVTRPDKVVCVGMNY | 101 | Q96GK7 | |
| YTLRAPRSPKMVQGS | 96 | P16860 | |
| PPPGTRVRAMAIYKQ | 151 | P04637 | |
| KAPQYTMAARVEPPG | 196 | Q96PU9 | |
| DMVPRSAEPGYLVTK | 576 | Q9Y5G1 | |
| KMAYLDQTLSPRPGT | 811 | Q96FC9 | |
| RRPAPQKALYSTAME | 351 | Q99755 | |
| PSMRKRLYSLPQQVG | 6 | Q9Y3Q4 | |
| MYQGPPDTAEIIKTL | 66 | P82909 | |
| GKMSQRQGKEAYPTP | 41 | Q9BZF1 | |
| GFGSPVETKYPLMQR | 171 | Q58A45 | |
| MAAAQPKYPAGATAR | 1 | Q9UBL9 | |
| YGMRFNVIQPGPIKT | 231 | Q16698 | |
| MEQPNSKGYSLGRTP | 1 | Q9P2D7 | |
| ATDEGMPKSYLPQTV | 896 | P40189 | |
| MANIPLPEYTRRDGK | 1066 | Q9Y4C1 | |
| MQRGQPLSPEKYVTS | 366 | P01871 | |
| PPSNLIAMEVSSKYV | 336 | Q99715 | |
| PVEEAPKGMLARGSY | 161 | P52565 | |
| VDKATFMVGSYGPRP | 136 | P52566 | |
| YVQVAPETKGPRQMA | 1486 | Q5JV73 | |
| TKGRVPYPGMNNREV | 461 | P06241 | |
| PASGMPVKFDRTLYN | 586 | P25067 | |
| AMEVETGKPRPRYDT | 526 | P29322 | |
| MSPPGYKLVTGDRNN | 281 | P17302 | |
| EKMAYLDQTLPRAPG | 811 | A8MPP1 | |
| VPLNTRVGTKRYMAP | 396 | P36894 | |
| RQQPMEGATYAPKIS | 231 | Q96DP5 | |
| TTMRDKVFGNYIPVP | 641 | Q9UHN6 | |
| KSSMDSRISLNYPPG | 316 | Q6ZMT9 | |
| RSPAQEDGKVYINMP | 76 | Q9UBK5 | |
| KIPYPGRTNADVMTA | 441 | P07948 | |
| TPARVQFKTYPGVMH | 196 | O95372 | |
| KMSRLLNTPDGSPYT | 691 | Q9UHC6 | |
| IQKQRMEYGPRPADT | 606 | Q12929 | |
| PTEYLSPDMQRQRKT | 346 | Q8IX15 | |
| AGPDPTTVYVDMRAL | 1326 | Q14689 | |
| VGTPMGSPYRDKITI | 766 | Q13002 | |
| ARNGMPLLKEVPRSY | 411 | Q9UKT9 | |
| MSPVYRDKSGSGPTQ | 71 | Q5H9B9 | |
| LKPMTFSIYEGQEPS | 31 | Q12864 | |
| ATGDMPTYQIRAPTA | 246 | Q03060 | |
| RYRSMADSPKSQDIP | 306 | Q1HG43 | |
| MKNPYPGIDSREELA | 121 | A6NLW8 | |
| VGTAMVYPEEAEPKQ | 831 | Q16531 | |
| RVRGANPEKPYAMAL | 641 | Q8WYK1 | |
| PDQLVSYMKAQGIRP | 551 | Q9HCH3 | |
| ASMSVTPVYKVPAGA | 761 | Q5VU65 | |
| GSVLVMYGSPPSKNE | 291 | Q8NGC1 | |
| TKGVLMYQPSSVRVP | 501 | O75928 | |
| RMSPEFVAVQPGKSV | 51 | Q14773 | |
| ANAEYMSPSGKVPFI | 61 | O75431 | |
| PLRNKEAGRYPMSAL | 296 | O95197 | |
| MPTQELGLPAYRKFD | 391 | Q9NP81 | |
| LYMKVPGSRTPGHQE | 1081 | O14607 | |
| QGPSSDYVVVKMIPD | 1916 | Q92673 | |
| YRMELAQAGTPAPTK | 386 | Q99932 | |
| TDDKKVPGRMYSNNP | 146 | Q9P0V3 | |
| KDMVPLSQLAYGPAV | 221 | Q8WV15 | |
| PKMNGALPSDAVGYR | 6 | Q8WUX1 | |
| MYLETDPSGRDKRTP | 676 | Q9Y6U3 | |
| YMSPENPALAVAIKT | 441 | Q05397 | |
| RKQVIYMDAPAPENG | 1266 | P25391 | |
| VGVNLRSTMPPEKCY | 261 | O60508 | |
| LGPPLMEKQVFAYST | 536 | Q5T5P2 | |
| MAKTLSEVDYAPAGP | 1126 | O15357 | |
| PEKMNEVGLTRGYSP | 766 | Q13796 | |
| NKTTIRMTYPEGAPL | 236 | Q9UNP4 | |
| STAAPAYGLPKRMVL | 641 | Q96SI9 | |
| FMYLRPPSKESVEQG | 256 | Q8NGP6 | |
| MYQLESGKLPRSPSF | 111 | Q9P0N9 | |
| MAGPRYPVSVQGAAL | 1 | Q8NFA2 | |
| YSGLKPTMIRAFPAN | 266 | Q9Y619 | |
| YGMSPPGSVADKRKN | 21 | Q96A35 | |
| DNGKPPTLVTSMIDY | 176 | O94818 | |
| RQALVVGKPSPYMFE | 206 | Q96GD0 | |
| RGQMPENPYSEVGKI | 981 | Q9UPX8 | |
| RATALAGTKPYMAPE | 246 | Q86UX6 | |
| PSLPVIQSTYGMKTD | 771 | P35712 | |
| RNALVGGYKNPSMIP | 296 | Q8N9L9 | |
| PQPVNGEIRVKSMEY | 326 | O00327 | |
| RGKYSDPMEIPANEA | 141 | Q9NPF2 | |
| PGYSVETNILPTKMR | 406 | G9CGD6 | |
| PGYSVETNILPTKMR | 406 | Q6P9H4 | |
| MPKNAVVILRYGPYS | 1 | Q8N6V4 | |
| KQREEYQPATPGLGM | 71 | Q9BVK6 | |
| PGRNRYTVMSGTPEK | 381 | O95398 | |
| VYNLLTPDSKMGEPV | 746 | Q9UHF7 | |
| SSERGSPIEKYMRPA | 1061 | Q9UHF7 | |
| VPKALEPYVTEMAQG | 326 | Q14186 | |
| SPVDVVKTRYMNSPP | 236 | P55916 | |
| EYLQPNPASRAKLTM | 56 | Q99961 | |
| ERLPTVPLSGMYNKS | 211 | O14562 | |
| LKEETGPSYQRAPQM | 156 | Q9UMS6 | |
| LDPVQVKMSRPTQYS | 91 | Q0P670 | |
| GQMIIPSREKSYSPT | 246 | B3KS81 | |
| QMQRKSEAPSYIAVP | 601 | Q9UQR0 | |
| KNYSVSAGDPPVTAM | 501 | A6NJ88 | |
| PGRSPISVAAAAIYM | 246 | Q00403 | |
| AGLYNDSEPPRKTMR | 101 | Q96ES7 | |
| MTKTIEYLQPNPASR | 51 | Q99962 | |
| PGRQMQRSYTAPDKT | 996 | O94964 | |
| RMKYNTEGRVSPSPS | 551 | Q5JSH3 | |
| PPIRNVTVAYKFHMG | 41 | Q9Y6I9 | |
| DPVVAQGTAPLMYSR | 466 | A0A0J9YWL9 | |
| QAMGVYGALTKAPVP | 311 | Q9UJZ1 | |
| TMVEARNGAGPIKSY | 311 | Q569K4 | |
| YRSKMDGEATSPLPR | 961 | Q86UU1 | |
| VPKALEPYVTEMAQG | 321 | Q5H9I0 | |
| RVPYSKETAVMPCGR | 336 | Q8IYW5 | |
| MNDPKTLTPERSYGS | 271 | Q9NZV7 | |
| VPPKGAYNVAVMFDR | 166 | A7E2V4 | |
| ERPQEGYFSSVKMPS | 131 | Q8N141 | |
| GAASKPVDDPSMYQL | 2101 | Q9Y4G6 | |
| PGASRIYPVAAVMIT | 61 | A2RUT3 | |
| DMVTVPKSPPAYARS | 56 | Q8N5H7 | |
| SPPSRAQMKRELYNG | 2281 | Q92508 | |
| VVDSEALQVYMKPPA | 1201 | Q00341 | |
| ETPTGAISQYKERMP | 1221 | Q9Y4F4 | |
| MPTPTGAKVDYIQGT | 1001 | Q8NFY4 | |
| PMYGVTASARTKPRP | 231 | Q9NSU2 | |
| KLPPYVSNMDRLGDS | 226 | A4D1P6 | |
| MRSDPVTLNVLYGPD | 226 | Q15238 | |
| PNDKVMGPGVSYLVR | 151 | P29353 | |
| QDSAMLGSKSPDPYR | 901 | P18583 | |
| RMTSPPDYRVGDKIA | 276 | P51854 | |
| YGMQDPGVSFVPKTL | 481 | O95405 | |
| KPVPMEFEAYINASG | 281 | Q9HAW7 | |
| VRMGTEKYIPPNESN | 226 | Q6ZT98 | |
| VTKGRVPYPGMVNRE | 466 | P07947 | |
| DPGLPKMQVIRNYSG | 591 | Q9UKW4 | |
| KMQVIRNYSGTPPPA | 596 | Q9UKW4 | |
| EYQMALSPPASRGKL | 546 | Q8N5Q1 | |
| SMYIDRPPSGKTPQQ | 171 | Q13094 | |
| APVMRERKVIPGSYN | 1756 | Q9NR99 | |
| EVTAPGAPAYRVLME | 1236 | Q9Y4I1 | |
| TPEERAQGYPKMAAA | 161 | P17050 | |
| VYAVNAIGMSRPSPA | 846 | Q14896 | |
| NYKATPVSMTPEIER | 661 | O76041 |